| Gradient Health, Inc. | SEC Form D Equity · Form D reports $2.13M soldSource quote- Filed Oct 7, 2026 · SEC Form D ↗
“Name of Issuer: Gradient Health, Inc.; CIK: 1914365; Address: Durham, NC; Submission type: D; Filing date: 2026-10-07; Industry Group: Other Health Care; Date of First Sale: 2026-10-06; Types of Securities Offered: Equity, Other (Shares of Issuer preferred stock and the issuer capital stock into which such preferred stock may convert.); Business combination transaction: false; Total Offering Amount: 2132720; Total Amount Sold: 2132720; Federal exemptions: 06b”
| Oct 6, 2026 | SEC Form D ↗ |
| Ensho Therapeutics | SEC Form D Equity · Form D reports $7.28M sold of $15.6M offeredSource quote- Filed Oct 15, 2026 · SEC Form D ↗
“Name of Issuer: Ensho Therapeutics, Inc.; CIK: 2032849; Address: Woodcliff Lake, NJ; Submission type: D; Filing date: 2026-10-15; Industry Group: Biotechnology; Date of First Sale: 2026-10-02; Types of Securities Offered: Equity, Security to be acquired; Business combination transaction: false; Total Offering Amount: 15604179; Total Amount Sold: 7281948; Federal exemptions: 06b”
| Oct 2, 2026 | SEC Form D ↗ |
| Lungpacer Medical | SEC Form D Debt / note · Form D reports $7.83M sold of $30M offeredSource quote- Filed Oct 14, 2026 · SEC Form D ↗
“Name of Issuer: Lungpacer Medical, Inc.; CIK: 1708893; Address: Exton, PA; Submission type: D; Filing date: 2026-10-14; Industry Group: Other Health Care; Date of First Sale: 2026-09-30; Types of Securities Offered: Debt, Other (Unsecured Convertible Promissory Notes); Business combination transaction: false; Total Offering Amount: 30000000; Total Amount Sold: 7833333; Federal exemptions: 06b”
| Sep 30, 2026 | SEC Form D ↗ |
| J3 Bioscience | SEC Form D Debt / note · Form D reports $50K soldSource quote- Filed Oct 16, 2026 · SEC Form D ↗
“Name of Issuer: J3 BIOSCIENCE, INC.; CIK: 1408012; Address: Salt Lake City, UT; Submission type: D; Filing date: 2026-10-16; Industry Group: Other Health Care; Date of First Sale: 2026-09-30; Types of Securities Offered: Debt, Option/warrant; Business combination transaction: false; Total Offering Amount: 50000; Total Amount Sold: 50000; Federal exemptions: 06b”
| Sep 30, 2026 | SEC Form D ↗ |
| BioStem Technologies | SEC Form D Equity · Form D reports $3M soldSource quote- Filed Oct 9, 2026 · SEC Form D ↗
“Name of Issuer: BioStem Technologies, Inc.; CIK: 1658678; Address: Pompano Beach, FL; Submission type: D; Filing date: 2026-10-09; Industry Group: Biotechnology; Date of First Sale: 2026-09-29; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 3000000; Federal exemptions: 06b”
| Sep 29, 2026 | SEC Form D ↗ |
| BioVentrix | SEC Form D Debt / note · Form D reports $1.2M sold of $3M offeredSource quote- Filed Oct 8, 2026 · SEC Form D ↗
“Name of Issuer: BIOVENTRIX, INC.; CIK: 1283259; Address: Mansfield, MA; Submission type: D; Filing date: 2026-10-08; Industry Group: Biotechnology; Date of First Sale: 2026-09-29; Types of Securities Offered: Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 1200000; Federal exemptions: 06b”
| Sep 29, 2026 | SEC Form D ↗ |
| Coeurative | SEC Form D Equity · Form D reports $100K sold of $2M offeredSource quote- Filed Oct 13, 2026 · SEC Form D ↗
“Name of Issuer: Coeurative, Inc.; CIK: 1577355; Address: Roanoke, VA; Submission type: D; Filing date: 2026-10-13; Industry Group: Other Health Care; Date of First Sale: 2026-09-27; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 2000000; Total Amount Sold: 100000; Federal exemptions: 06b”
| Sep 27, 2026 | SEC Form D ↗ |
| EpiVario Inc. | SEC Form D Debt / note · Form D reports $185K sold of $500K offeredSource quote- Filed Oct 13, 2026 · SEC Form D ↗
“Name of Issuer: EpiVario Inc.; CIK: 1753351; Address: Philadelphia, PA; Submission type: D; Filing date: 2026-10-13; Industry Group: Pharmaceuticals; Date of First Sale: 2026-09-25; Types of Securities Offered: Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 500000; Total Amount Sold: 185000; Federal exemptions: 06b”
| Sep 25, 2026 | SEC Form D ↗ |
| OncoNano Medicine | SEC Form D Equity · Form D reports $10.05M sold of $15M offeredSource quote- Filed Oct 8, 2026 · SEC Form D ↗
“Name of Issuer: OncoNano Medicine, Inc.; CIK: 1735726; Address: Dallas, TX; Submission type: D; Filing date: 2026-10-08; Industry Group: Biotechnology; Date of First Sale: 2026-09-23; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 15000000; Total Amount Sold: 10051615; Federal exemptions: 06b”
| Sep 23, 2026 | SEC Form D ↗ |
| PreciseDx | SEC Form D Equity · Form D reports $3.7M soldSource quote- Filed Oct 7, 2026 · SEC Form D ↗
“Name of Issuer: PreciseDx, Inc.; CIK: 2013833; Address: New York, NY; Submission type: D; Filing date: 2026-10-07; Industry Group: Other Health Care; Date of First Sale: 2026-09-23; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 3699998; Total Amount Sold: 3699998; Federal exemptions: 06b”
| Sep 23, 2026 | SEC Form D ↗ |
| Anvion Bio, Inc. | SEC Form D Equity · Form D reports $100K sold of $1M offeredSource quote- Filed Oct 7, 2026 · SEC Form D ↗
“Name of Issuer: Anvion Bio, Inc.; CIK: 2158000; Address: San Diego, CA; Submission type: D; Filing date: 2026-10-07; Industry Group: Pharmaceuticals; Date of First Sale: 2026-09-22; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 1000000; Total Amount Sold: 100000; Federal exemptions: 06b”
| Sep 22, 2026 | SEC Form D ↗ |
| Pace Pharmaceuticals, Inc. | SEC Form D SAFE · Form D reports $50K sold (offering size open-ended)Source quote- Filed Sep 28, 2026 · SEC Form D ↗
“Name of Issuer: Pace Pharmaceuticals, Inc.; CIK: 2157304; Address: Cupertino, CA; Submission type: D; Filing date: 2026-09-28; Industry Group: Biotechnology; Date of First Sale: 2026-09-18; Types of Securities Offered: Other (Simple Agreement for Future Equity); Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 50000; Federal exemptions: 06c”
| Sep 18, 2026 | SEC Form D ↗ |
| Navigator Medicines | SEC Form D Equity · Form D reports $10M sold of $40M offeredSource quote- Filed Sep 25, 2026 · SEC Form D ↗
“Name of Issuer: Navigator Medicines, Inc.; CIK: 2035715; Address: San Mateo, CA; Submission type: D; Filing date: 2026-09-25; Industry Group: Biotechnology; Date of First Sale: 2026-09-18; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 40000000; Total Amount Sold: 10000000; Federal exemptions: 06b”
| Sep 18, 2026 | SEC Form D ↗ |
| Virtual Incision | SEC Form D Equity · Form D reports $35.14M sold of $80.14M offeredSource quote- Filed Oct 5, 2026 · SEC Form D ↗
“Name of Issuer: Virtual Incision Corp; CIK: 1380771; Address: Lincoln, NE; Submission type: D; Filing date: 2026-10-05; Industry Group: Biotechnology; Date of First Sale: 2026-09-18; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 80140041; Total Amount Sold: 35140060; Federal exemptions: 06b”
| Sep 18, 2026 | SEC Form D ↗ |
| Vetmab Biosciences, Inc. | SEC Form D Equity · Form D reports $11.44M sold of $11.94M offeredSource quote- Filed Sep 29, 2026 · SEC Form D ↗
“Name of Issuer: Vetmab Biosciences, Inc.; CIK: 1932050; Address: San Diego, CA; Submission type: D; Filing date: 2026-09-29; Industry Group: Biotechnology; Date of First Sale: 2026-09-17; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 11944990; Total Amount Sold: 11439990; Federal exemptions: 06b”
| Sep 17, 2026 | SEC Form D ↗ |
| Altay Therapeutics, Inc. | SEC Form D Equity · Form D reports $15.74M sold of $45.07M offeredSource quote- Filed Oct 2, 2026 · SEC Form D ↗
“Name of Issuer: Altay Therapeutics, Inc.; CIK: 2157551; Address: San Carlos, CA; Submission type: D; Filing date: 2026-10-02; Industry Group: Biotechnology; Date of First Sale: 2026-09-17; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 45067885; Total Amount Sold: 15738155; Federal exemptions: 06b”
| Sep 17, 2026 | SEC Form D ↗ |
| CAD Therapeutics, Inc. | SEC Form D Equity · Form D reports $4M sold of $10M offeredSource quote- Filed Oct 2, 2026 · SEC Form D ↗
“Name of Issuer: CAD Therapeutics, Inc.; CIK: 2157566; Address: New York, NY; Submission type: D; Filing date: 2026-10-02; Industry Group: Biotechnology; Date of First Sale: 2026-09-17; Types of Securities Offered: Equity, Other (SERIES A COMMON STOCK); Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 4000000; Federal exemptions: 06b”
| Sep 17, 2026 | SEC Form D ↗ |
| Huxley Medical | SEC Form D Debt / note · Form D reports $11.02M sold of $11.7M offeredSource quote- Filed Sep 30, 2026 · SEC Form D ↗
“Name of Issuer: Huxley Medical, Inc.; CIK: 1869701; Address: Atlanta, GA; Submission type: D; Filing date: 2026-09-30; Industry Group: Other Health Care; Date of First Sale: 2026-09-16; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 11700000; Total Amount Sold: 11019335; Federal exemptions: 06b”
| Sep 16, 2026 | SEC Form D ↗ |
| Jupiter BioMedical Research | SEC Form D Equity · Form D reports $30K sold of $1M offeredSource quote- Filed Sep 21, 2026 · SEC Form D ↗
“Name of Issuer: Jupiter Biomedical Research, Inc.; CIK: 1694280; Address: Palm Beach Gardens, FL; Submission type: D; Filing date: 2026-09-21; Industry Group: Biotechnology; Date of First Sale: 2026-09-15; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 1000000; Total Amount Sold: 30000; Federal exemptions: 06b, 4a5”
| Sep 15, 2026 | SEC Form D ↗ |
| Toetal Solutions | SEC Form D Equity · Form D reports $50K sold of $250K offeredSource quote- Filed Sep 24, 2026 · SEC Form D ↗
“Name of Issuer: Toetal Solutions, Inc.; CIK: 1888204; Address: Malvern, PA; Submission type: D; Filing date: 2026-09-24; Industry Group: Other Health Care; Date of First Sale: 2026-09-15; Types of Securities Offered: Equity, Option/warrant, Security to be acquired, Other (Security to be acquired upon exercise.); Business combination transaction: false; Total Offering Amount: 250000; Total Amount Sold: 50000; Federal exemptions: 06b”
| Sep 15, 2026 | SEC Form D ↗ |
| Dignify Therapeutics | SEC Form D Debt / note · Form D reports $800K sold of $3M offeredSource quote- Filed Sep 25, 2026 · SEC Form D ↗
“Name of Issuer: Dignify Therapeutics, LLC; CIK: 1622906; Address: Research Triangle Park, NC; Submission type: D; Filing date: 2026-09-25; Industry Group: Pharmaceuticals; Date of First Sale: 2026-09-15; Types of Securities Offered: Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 800000; Federal exemptions: 06b”
| Sep 15, 2026 | SEC Form D ↗ |
| GT Biopharma | SEC Form D Equity · Form D reports $7.75M sold of $38.96M offeredSource quote- Filed Sep 29, 2026 · SEC Form D ↗
“Name of Issuer: GT Biopharma, Inc.; CIK: 109657; Address: San Francisco, CA; Submission type: D; Filing date: 2026-09-29; Industry Group: Biotechnology; Date of First Sale: 2026-09-14; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 38958054; Total Amount Sold: 7750000; Federal exemptions: 06b”
| Sep 14, 2026 | SEC Form D ↗ |
| Harvard Apparatus Regenerative Technology | SEC Form D Equity · Form D reports $2.84M sold of $3M offeredSource quote- Filed Sep 14, 2026 · SEC Form D ↗
“Name of Issuer: Harvard Apparatus Regenerative Technology, Inc.; CIK: 1563665; Address: Holliston, MA; Submission type: D; Filing date: 2026-09-14; Industry Group: Biotechnology; Date of First Sale: 2026-09-11; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 2838911; Federal exemptions: 06b”
| Sep 11, 2026 | SEC Form D ↗ |
| OpZira | SEC Form D Equity · Form D reports $2.02M sold of $5M offeredSource quote- Filed Sep 15, 2026 · SEC Form D ↗
“Name of Issuer: OpZira, Inc.; CIK: 2124535; Address: Middletown, PA; Submission type: D; Filing date: 2026-09-15; Industry Group: Other Technology; Date of First Sale: 2026-09-09; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 5000000; Total Amount Sold: 2025000; Federal exemptions: 06b”
| Sep 9, 2026 | SEC Form D ↗ |
| Theia Imaging LLC | SEC Form D SAFE · Form D reports $160K sold of $1M offeredSource quote- Filed Sep 17, 2026 · SEC Form D ↗
“Name of Issuer: Theia Imaging LLC; CIK: 2155415; Address: Durham, NC; Submission type: D; Filing date: 2026-09-17; Industry Group: Other Health Care; Date of First Sale: 2026-09-09; Types of Securities Offered: Other (SAFE (Simple Agreement for Future Equity)); Business combination transaction: false; Total Offering Amount: 1000000; Total Amount Sold: 160000; Federal exemptions: 06b”
| Sep 9, 2026 | SEC Form D ↗ |
| Caspian Therapeutics, Inc. | SEC Form D Equity · Form D reports $50M soldSource quote- Filed Sep 23, 2026 · SEC Form D ↗
“Name of Issuer: Caspian Therapeutics, Inc.; CIK: 2156247; Address: San Diego, CA; Submission type: D; Filing date: 2026-09-23; Industry Group: Biotechnology; Date of First Sale: 2026-09-08; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 50000000; Total Amount Sold: 50000000; Federal exemptions: 06b”
| Sep 8, 2026 | SEC Form D ↗ |
| Encision | SEC Form D Equity · Form D reports $80K soldSource quote- Filed Sep 17, 2026 · SEC Form D ↗
“Name of Issuer: ENCISION INC; CIK: 930775; Address: Boulder, CO; Submission type: D; Filing date: 2026-09-17; Industry Group: Other Health Care; Date of First Sale: 2026-09-08; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 80000; Total Amount Sold: 80000; Federal exemptions: 06b”
| Sep 8, 2026 | SEC Form D ↗ |
| Aqur Biosciences | SEC Form D Equity · Form D reports $1.5M soldSource quote- Filed Sep 18, 2026 · SEC Form D ↗
“Name of Issuer: Aqur Biosciences, Inc.; CIK: 2094075; Address: Westlake Village, CA; Submission type: D; Filing date: 2026-09-18; Industry Group: Pharmaceuticals; Date of First Sale: 2026-09-03; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 1500000; Total Amount Sold: 1500000; Federal exemptions: 06b”
| Sep 3, 2026 | SEC Form D ↗ |
| seqWell, Inc. | SEC Form D Equity · Form D reports $960K sold of $1M offeredSource quote- Filed Sep 10, 2026 · SEC Form D ↗
“Name of Issuer: seqWell Inc.; CIK: 1679720; Address: Beverly, MA; Submission type: D; Filing date: 2026-09-10; Industry Group: Other Technology; Date of First Sale: 2026-09-01; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 1000000; Total Amount Sold: 960110; Federal exemptions: 06b”
| Sep 1, 2026 | SEC Form D ↗ |
| Coologics | SEC Form D SAFE · Form D reports $1M sold of $2.5M offeredSource quote- Filed Sep 10, 2026 · SEC Form D ↗
“Name of Issuer: Coologics, Inc.; CIK: 2150705; Address: Grove City, OH; Submission type: D; Filing date: 2026-09-10; Industry Group: Other; Date of First Sale: 2026-09-01; Types of Securities Offered: Other (Simple Agreement for Future Equity (SAFE)); Business combination transaction: false; Total Offering Amount: 2500000; Total Amount Sold: 1000000; Federal exemptions: 06b”
| Sep 1, 2026 | SEC Form D ↗ |
| Myris Therapeutics | SEC Form D Debt / note · Form D reports $500K sold of $4.5M offeredSource quote- Filed Oct 14, 2026 · SEC Form D ↗
“Name of Issuer: Myris Therapeutics, Inc.; CIK: 1924725; Address: Sharpsburg, PA; Submission type: D; Filing date: 2026-10-14; Industry Group: Biotechnology; Date of First Sale: 2026-09-01; Types of Securities Offered: Other (Convertible Promissory Notes); Business combination transaction: false; Total Offering Amount: 4500000; Total Amount Sold: 500000; Federal exemptions: 06b”
| Sep 1, 2026 | SEC Form D ↗ |
| Intelligent Bio Solutions | SEC Form D Equity · Form D reports $4.98M soldSource quote- Filed Sep 14, 2026 · SEC Form D ↗
“Name of Issuer: INTELLIGENT BIO SOLUTIONS INC.; CIK: 1725430; Address: New York, NY; Submission type: D; Filing date: 2026-09-14; Industry Group: Other Health Care; Date of First Sale: 2026-08-31; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 4979631; Total Amount Sold: 4979631; Federal exemptions: 06b”
| Aug 31, 2026 | SEC Form D ↗ |
| 3Helix | SEC Form D Equity · Form D reports $7.84M sold of $10M offeredSource quote- Filed Sep 21, 2026 · SEC Form D ↗
“Name of Issuer: 3Helix, Inc.; CIK: 2001622; Address: Salt Lake City, UT; Submission type: D; Filing date: 2026-09-21; Industry Group: Biotechnology; Date of First Sale: 2026-08-31; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 7835028; Federal exemptions: 06b”
| Aug 31, 2026 | SEC Form D ↗ |
| Retham Technologies LLC | SEC Form D Equity · Form D reports $1.06M sold of $1.5M offeredSource quote- Filed Sep 11, 2026 · SEC Form D ↗
“Name of Issuer: Retham Technologies, Inc.; CIK: 2144681; Address: Wauwatosa, WI; Submission type: D; Filing date: 2026-09-11; Industry Group: Other; Date of First Sale: 2026-08-28; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 1500000; Total Amount Sold: 1060000; Federal exemptions: 06b”
| Aug 28, 2026 | SEC Form D ↗ |
| Tempo Therapeutics Inc | SEC Form D Debt / note · Form D reports $14M sold of $14.5M offeredSource quote- Filed Sep 11, 2026 · SEC Form D ↗
“Name of Issuer: Tempo Therapeutics, Inc.; CIK: 1813688; Address: San Diego, CA; Submission type: D; Filing date: 2026-09-11; Industry Group: Biotechnology; Date of First Sale: 2026-08-27; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 14500000; Total Amount Sold: 14000000; Federal exemptions: 06b”
| Aug 27, 2026 | SEC Form D ↗ |
| Alzheon | SEC Form D Equity · Form D reports $78.8M sold of $500M offeredSource quote- Filed Sep 10, 2026 · SEC Form D ↗
“Name of Issuer: ALZHEON, INC.; CIK: 1582636; Address: Framingham, MA; Submission type: D; Filing date: 2026-09-10; Industry Group: Biotechnology; Date of First Sale: 2026-08-26; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 499999999; Total Amount Sold: 78797184; Federal exemptions: 06b”
| Aug 26, 2026 | SEC Form D ↗ |
| Cloverleaf Bio, Inc. | SEC Form D Equity · Form D reports $14.8M sold of $29.6M offeredSource quote- Filed Sep 9, 2026 · SEC Form D ↗
“Name of Issuer: Cloverleaf Bio, Inc.; CIK: 2153574; Address: New Haven, CT; Submission type: D; Filing date: 2026-09-09; Industry Group: Biotechnology; Date of First Sale: 2026-08-24; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 29599977; Total Amount Sold: 14799988; Federal exemptions: 06b”
| Aug 24, 2026 | SEC Form D ↗ |
| Malcova Inc. | SEC Form D Equity · Form D reports $1.21M sold of $2M offeredSource quote- Filed Sep 8, 2026 · SEC Form D ↗
“Name of Issuer: Malcova, Inc; CIK: 2152940; Address: Newark, CA; Submission type: D; Filing date: 2026-09-08; Industry Group: Other Technology; Date of First Sale: 2026-08-24; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 2000000; Total Amount Sold: 1214000; Federal exemptions: 06b”
| Aug 24, 2026 | SEC Form D ↗ |
| Orthobond | SEC Form D Debt / note · Form D reports $8.35M sold of $10M offeredSource quote- Filed Sep 1, 2026 · SEC Form D ↗
“Name of Issuer: Orthobond Corp; CIK: 1329147; Address: Monmouth Junction, NJ; Submission type: D; Filing date: 2026-09-01; Industry Group: Other Technology; Date of First Sale: 2026-08-24; Types of Securities Offered: Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 8346000; Federal exemptions: 06b”
| Aug 24, 2026 | SEC Form D ↗ |
| Laurentide Therapeutics Inc. | SEC Form D Equity · Form D reports $100K soldSource quote- Filed Sep 28, 2026 · SEC Form D ↗
“Name of Issuer: Laurentide Therapeutics Inc.; CIK: 2157396; Address: Atlanta, GA; Submission type: D; Filing date: 2026-09-28; Industry Group: Pharmaceuticals; Date of First Sale: 2026-08-20; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 100000; Total Amount Sold: 99999; Federal exemptions: 06b”
| Aug 20, 2026 | SEC Form D ↗ |
| Jupiter Neurosciences | SEC Form D Equity · Form D reports $775K soldSource quote- Filed Sep 4, 2026 · SEC Form D ↗
“Name of Issuer: JUPITER NEUROSCIENCES, INC.; CIK: 1679628; Address: Palm Beach Gardens, FL; Submission type: D; Filing date: 2026-09-04; Industry Group: Other Health Care; Date of First Sale: 2026-08-20; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 774787; Total Amount Sold: 774787; Federal exemptions: 06b”
| Aug 20, 2026 | SEC Form D ↗ |
| Avery Therapeutics | SEC Form D Equity · Form D reports $8.47M sold of $15.4M offeredSource quote- Filed Sep 21, 2026 · SEC Form D ↗
“Name of Issuer: Avery Therapeutics, Inc.; CIK: 1708135; Address: Tucson, AZ; Submission type: D; Filing date: 2026-09-21; Industry Group: Biotechnology; Date of First Sale: 2026-08-19; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 15400000; Total Amount Sold: 8468859; Federal exemptions: 06b”
| Aug 19, 2026 | SEC Form D ↗ |
| Halia Therapeutics | SEC Form D Equity + debt/notes · Form D reports $3.49M sold of $20M offeredSource quote- Filed Aug 31, 2026 · SEC Form D ↗
“Name of Issuer: Halia Therapeutics, Inc.; CIK: 1829255; Address: Lehi, UT; Submission type: D; Filing date: 2026-08-31; Industry Group: Biotechnology; Date of First Sale: 2026-08-17; Types of Securities Offered: Equity, Option/warrant, Other (Convertible Promissory Notes); Business combination transaction: false; Total Offering Amount: 20000000; Total Amount Sold: 3486474; Federal exemptions: 06b”
| Aug 17, 2026 | SEC Form D ↗ |
| Iambic Therapeutics | SEC Form D Debt / note · Form D reports $65.97M sold of $66.5M offeredSource quote- Filed Sep 9, 2026 · SEC Form D ↗
“Name of Issuer: Iambic Therapeutics, Inc.; CIK: 1997038; Address: San Diego, CA; Submission type: D; Filing date: 2026-09-09; Industry Group: Biotechnology; Date of First Sale: 2026-08-14; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 66500000; Total Amount Sold: 65965000; Federal exemptions: 06b”
| Aug 14, 2026 | SEC Form D ↗ |
| Acuitive Technologies | SEC Form D SAFE · Form D reports $1.88M sold of $3M offeredSource quote- Filed Sep 24, 2026 · SEC Form D ↗
“Name of Issuer: Acuitive Technologies, Inc.; CIK: 1864239; Address: Allendale, NJ; Submission type: D; Filing date: 2026-09-24; Industry Group: Other Health Care; Date of First Sale: 2026-08-14; Types of Securities Offered: Other (Simple Agreements for Future Equity (SAFEs)); Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 1875000; Federal exemptions: 06b”
| Aug 14, 2026 | SEC Form D ↗ |
| Turn Therapeutics | SEC Form D Equity · Form D reports $1.65M sold (offering size open-ended)Source quote- Filed Aug 26, 2026 · SEC Form D ↗
“Name of Issuer: Turn Therapeutics Inc.; CIK: 2023016; Address: Westlake Village, CA; Submission type: D; Filing date: 2026-08-26; Industry Group: Biotechnology; Date of First Sale: 2026-08-14; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 1650000; Federal exemptions: 06b”
| Aug 14, 2026 | SEC Form D ↗ |
| Thetis Pharmaceuticals LLC | SEC Form D Debt / note · Form D reports $560K sold of $1M offeredSource quote- Filed Oct 13, 2026 · SEC Form D ↗
“Name of Issuer: Thetis Pharmaceuticals LLC; CIK: 1528491; Address: Deep River, CT; Submission type: D; Filing date: 2026-10-13; Industry Group: Pharmaceuticals; Date of First Sale: 2026-08-13; Types of Securities Offered: Debt, Option/warrant; Business combination transaction: false; Total Offering Amount: 1000000; Total Amount Sold: 560300; Federal exemptions: 06b”
| Aug 13, 2026 | SEC Form D ↗ |
| Noveome Biotherapeutics | SEC Form D Debt / note · Form D reports $6.75M sold of $15M offeredSource quote- Filed Aug 27, 2026 · SEC Form D ↗
“Name of Issuer: Noveome Biotherapeutics, Inc.; CIK: 1478304; Address: Pittsburgh, PA; Submission type: D; Filing date: 2026-08-27; Industry Group: Biotechnology; Date of First Sale: 2026-08-12; Types of Securities Offered: Debt, Other (Convertible promissory notes); Business combination transaction: false; Total Offering Amount: 15000000; Total Amount Sold: 6750503; Federal exemptions: 06b”
| Aug 12, 2026 | SEC Form D ↗ |
| Aptevo Therapeutics | SEC Form D Equity · Form D reports $3.47M soldSource quote- Filed Aug 26, 2026 · SEC Form D ↗
“Name of Issuer: Aptevo Therapeutics Inc.; CIK: 1671584; Address: Seattle, WA; Submission type: D; Filing date: 2026-08-26; Industry Group: Pharmaceuticals; Date of First Sale: 2026-08-12; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 3472683; Total Amount Sold: 3472683; Federal exemptions: 06c”
| Aug 12, 2026 | SEC Form D ↗ |
| Femasys | SEC Form D Equity · Form D reports $30M soldSource quote- Filed Aug 20, 2026 · SEC Form D ↗
“Name of Issuer: FEMASYS INC; CIK: 1339005; Address: Suwanee, GA; Submission type: D; Filing date: 2026-08-20; Industry Group: Biotechnology; Date of First Sale: 2026-08-10; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 30000000; Total Amount Sold: 30000000; Federal exemptions: 06b”
| Aug 10, 2026 | SEC Form D ↗ |
| OS Therapies | SEC Form D Equity + debt/notes · Form D reports $5M sold of $10M offeredSource quote- Filed Aug 25, 2026 · SEC Form D ↗
“Name of Issuer: OS Therapies Inc; CIK: 1795091; Address: Grasonville, MD; Submission type: D; Filing date: 2026-08-25; Industry Group: Biotechnology; Date of First Sale: 2026-08-10; Types of Securities Offered: Equity, Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 5000000; Federal exemptions: 06b”
| Aug 10, 2026 | SEC Form D ↗ |
| Superluminal Medicines | SEC Form D Equity · Form D reports $65.48M soldSource quote- Filed Sep 3, 2026 · SEC Form D ↗
“Name of Issuer: Superluminal Medicines, Inc.; CIK: 1989478; Address: Boston, MA; Submission type: D; Filing date: 2026-09-03; Industry Group: Biotechnology; Date of First Sale: 2026-08-10; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 65480796; Total Amount Sold: 65480796; Federal exemptions: 06b”
| Aug 10, 2026 | SEC Form D ↗ |
| Auron Therapeutics | SEC Form D Debt / note · Form D reports $7.12M sold of $12M offeredSource quote- Filed Aug 13, 2026 · SEC Form D ↗
“Name of Issuer: Auron Therapeutics, Inc.; CIK: 1746139; Address: Wellesley, MA; Submission type: D; Filing date: 2026-08-13; Industry Group: Biotechnology; Date of First Sale: 2026-08-10; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 12000000; Total Amount Sold: 7118141; Federal exemptions: 06b”
| Aug 10, 2026 | SEC Form D ↗ |
| MalarVx | SEC Form D Debt / note · Form D reports $125K sold of $2.5M offeredSource quote- Filed Aug 25, 2026 · SEC Form D ↗
“Name of Issuer: MalarVx, Inc.; CIK: 1559688; Address: Seattle, WA; Submission type: D; Filing date: 2026-08-25; Industry Group: Biotechnology; Date of First Sale: 2026-08-08; Types of Securities Offered: Other (Promissory Note convertible into equity.); Business combination transaction: false; Total Offering Amount: 2500000; Total Amount Sold: 125000; Federal exemptions: 06b”
| Aug 8, 2026 | SEC Form D ↗ |
| Unravel Biosciences | SEC Form D Debt / note · Form D reports $4.1M sold of $4.5M offeredSource quote- Filed Aug 24, 2026 · SEC Form D ↗
“Name of Issuer: Unravel Biosciences, Inc.; CIK: 1876967; Address: Medford, MA; Submission type: D; Filing date: 2026-08-24; Industry Group: Biotechnology; Date of First Sale: 2026-08-07; Types of Securities Offered: Debt, Option/warrant; Business combination transaction: false; Total Offering Amount: 4500000; Total Amount Sold: 4100000; Federal exemptions: 06b”
| Aug 7, 2026 | SEC Form D ↗ |
| Cardiosense | SEC Form D Equity + debt/notes · Form D reports $26.14M sold of $42.01M offeredSource quote- Filed Aug 24, 2026 · SEC Form D ↗
“Name of Issuer: Cardiosense, Inc.; CIK: 1957335; Address: Chicago, IL; Submission type: D; Filing date: 2026-08-24; Industry Group: Other Health Care; Date of First Sale: 2026-08-07; Types of Securities Offered: Equity, Security to be acquired, Other (Convertible Promissory Notes have converted into equity in connection with this transaction); Business combination transaction: false; Total Offering Amount: 42012230; Total Amount Sold: 26137050; Federal exemptions: 06b”
| Aug 7, 2026 | SEC Form D ↗ |
| Aer Therapeutics | SEC Form D Debt / note · Form D reports $3M soldSource quote- Filed Aug 19, 2026 · SEC Form D ↗
“Name of Issuer: Aer Therapeutics, Inc.; CIK: 1959576; Address: Research Triangle Park, NC; Submission type: D; Filing date: 2026-08-19; Industry Group: Biotechnology; Date of First Sale: 2026-08-07; Types of Securities Offered: Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 3000000; Federal exemptions: 06b”
| Aug 7, 2026 | SEC Form D ↗ |
| Limber Prosthetics & Orthotics Inc. Filed as Limber Prosthetics, Inc. | SEC Form D Equity · Form D reports $135K sold of $1.88M offeredSource quote- Filed Aug 18, 2026 · SEC Form D ↗
“Name of Issuer: Limber Prosthetics, Inc.; CIK: 2072119; Address: San Diego, CA; Submission type: D; Filing date: 2026-08-18; Industry Group: Other Health Care; Date of First Sale: 2026-08-07; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 1875000; Total Amount Sold: 135343; Federal exemptions: 06b”
| Aug 7, 2026 | SEC Form D ↗ |
| InSitu Biologics | SEC Form D Debt / note · Form D reports $1.25M sold of $3.38M offeredSource quote- Filed Aug 10, 2026 · amended Oct 14, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: InSitu Biologics, Inc.; CIK: 1723443; Address: Oakdale, MN; Submission type: D/A; Filing date: 2026-10-14; Industry Group: Biotechnology; Date of First Sale: 2026-08-04; Types of Securities Offered: Debt, Option/warrant, Other (Convertible Promissory Note); Business combination transaction: false; Total Offering Amount: 3375000; Total Amount Sold: 1250000; Federal exemptions: 06b”
| Aug 4, 2026 | SEC Form D/A ↗ |
| Aegle Therapeutics | SEC Form D Equity · Form D reports $2.28M soldSource quote- Filed Aug 28, 2026 · SEC Form D ↗
“Name of Issuer: Aegle Therapeutics Corp; CIK: 1797825; Address: Woburn, MA; Submission type: D; Filing date: 2026-08-28; Industry Group: Biotechnology; Date of First Sale: 2026-08-04; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 2277698; Total Amount Sold: 2277698; Federal exemptions: 06b”
| Aug 4, 2026 | SEC Form D ↗ |
| Hepion Pharmaceuticals | SEC Form D Equity · Form D reports $3.06M soldSource quote- Filed Aug 5, 2026 · SEC Form D ↗
“Name of Issuer: Hepion Pharmaceuticals, Inc.; CIK: 1583771; Address: Red Bank, NJ; Submission type: D; Filing date: 2026-08-05; Industry Group: Biotechnology; Date of First Sale: 2026-07-31; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 3055000; Total Amount Sold: 3055000; Federal exemptions: 06b”
| Jul 31, 2026 | SEC Form D ↗ |
| Bioliberty | SEC Form D Equity · Form D reports $2.95M soldSource quote- Filed Aug 27, 2026 · SEC Form D ↗
“Name of Issuer: Bioliberty Ltd; CIK: 2151818; Address: Edinburgh, United Kingdom; Submission type: D; Filing date: 2026-08-27; Industry Group: Other Technology; Date of First Sale: 2026-07-31; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 2947097; Total Amount Sold: 2947097; Federal exemptions: 06b”
| Jul 31, 2026 | SEC Form D ↗ |
| Hyku Biosciences | SEC Form D Equity · Form D reports $8.61M soldSource quote- Filed Aug 13, 2026 · SEC Form D ↗
“Name of Issuer: HYKU BIOSCIENCES INC.; CIK: 1980518; Address: Concord, MA; Submission type: D; Filing date: 2026-08-13; Industry Group: Other; Date of First Sale: 2026-07-30; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 8612446; Total Amount Sold: 8612446; Federal exemptions: 06b”
| Jul 30, 2026 | SEC Form D ↗ |
| DalCor Pharmaceuticals Filed as DalCor Pharmaceuticals US, LLC | SEC Form D Equity · Form D reports $6.96M soldSource quote- Filed Aug 28, 2026 · SEC Form D ↗
“Name of Issuer: DalCor Pharmaceuticals US, LLC; CIK: 1673368; Address: Sarasota, FL; Submission type: D; Filing date: 2026-08-28; Industry Group: Pharmaceuticals; Date of First Sale: 2026-07-30; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 6958236; Total Amount Sold: 6958236; Federal exemptions: 06b”
| Jul 30, 2026 | SEC Form D ↗ |
| Trace Biosciences | SEC Form D Equity · Form D reports $8.33M sold of $16.23M offeredSource quote- Filed Aug 12, 2026 · SEC Form D ↗
“Name of Issuer: Trace Biosciences Inc.; CIK: 2147501; Address: Beaverton, OR; Submission type: D; Filing date: 2026-08-12; Industry Group: Biotechnology; Date of First Sale: 2026-07-28; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 16234498; Total Amount Sold: 8334499; Federal exemptions: 06b”
| Jul 28, 2026 | SEC Form D ↗ |
| PleoPharma | SEC Form D Debt / note · Form D reports $5.5M sold of $15M offeredSource quote- Filed Aug 10, 2026 · SEC Form D ↗
“Name of Issuer: PLEOPHARMA, INC.; CIK: 1801323; Address: Phoenixville, PA; Submission type: D; Filing date: 2026-08-10; Industry Group: Pharmaceuticals; Date of First Sale: 2026-07-28; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 15000000; Total Amount Sold: 5500000; Federal exemptions: 06b”
| Jul 28, 2026 | SEC Form D ↗ |
| Meduloc | SEC Form D Equity · Form D reports $1.84M soldSource quote- Filed Aug 6, 2026 · SEC Form D ↗
“Name of Issuer: Meduloc, Inc.; CIK: 2014714; Address: Del Mar, CA; Submission type: D; Filing date: 2026-08-06; Industry Group: Other Health Care; Date of First Sale: 2026-07-24; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 1843000; Total Amount Sold: 1843000; Federal exemptions: 06b”
| Jul 24, 2026 | SEC Form D ↗ |
| oRF Biologics | SEC Form D Equity · Form D reports $1.73M sold of $2.5M offeredSource quote- Filed Jul 31, 2026 · SEC Form D ↗
“Name of Issuer: ORF Biologics, Inc.; CIK: 2048350; Address: Tiffin, IA; Submission type: D; Filing date: 2026-07-31; Industry Group: Biotechnology; Date of First Sale: 2026-07-23; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 2500000; Total Amount Sold: 1734220; Federal exemptions: 06b”
| Jul 23, 2026 | SEC Form D ↗ |
| NextPoint Therapeutics | SEC Form D Equity · Form D reports $33.73M sold of $48.73M offeredSource quote- Filed Jul 30, 2026 · SEC Form D ↗
“Name of Issuer: NextPoint Therapeutics, Inc.; CIK: 1959209; Address: Cambridge, MA; Submission type: D; Filing date: 2026-07-30; Industry Group: Biotechnology; Date of First Sale: 2026-07-22; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 48729165; Total Amount Sold: 33728772; Federal exemptions: 06b”
| Jul 22, 2026 | SEC Form D ↗ |
| Integrated Biosciences | SEC Form D Equity · Form D reports $68.37M sold of $100M offeredSource quote- Filed Aug 5, 2026 · SEC Form D ↗
“Name of Issuer: Integrated Biosciences, Inc.; CIK: 2148371; Address: Redwood City, CA; Submission type: D; Filing date: 2026-08-05; Industry Group: Biotechnology; Date of First Sale: 2026-07-21; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 100000000; Total Amount Sold: 68374977; Federal exemptions: 06b”
| Jul 21, 2026 | SEC Form D ↗ |
| Jasper Therapeutics, Inc. | SEC Form D Equity · Form D reports $132M soldSource quote- Filed Aug 5, 2026 · SEC Form D ↗
“Name of Issuer: Jasper Therapeutics, Inc.; CIK: 1788028; Address: Redwood City, CA; Submission type: D; Filing date: 2026-08-05; Industry Group: Biotechnology; Date of First Sale: 2026-07-21; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 131999611; Total Amount Sold: 131999611; Federal exemptions: 06b”
| Jul 21, 2026 | SEC Form D ↗ |
| Theradaptive | SEC Form D Equity · Form D reports $36.16M sold of $77.93M offeredSource quote- Filed Aug 4, 2026 · SEC Form D ↗
“Name of Issuer: Theradaptive, Inc.; CIK: 2148461; Address: Frederick, MD; Submission type: D; Filing date: 2026-08-04; Industry Group: Biotechnology; Date of First Sale: 2026-07-21; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 77925166; Total Amount Sold: 36156177; Federal exemptions: 06b”
| Jul 21, 2026 | SEC Form D ↗ |
| Accipiter Biosciences | SEC Form D Equity · Form D reports $10.49M soldSource quote- Filed Jul 28, 2026 · SEC Form D ↗
“Name of Issuer: Accipiter Biosciences Inc.; CIK: 1973963; Address: Seattle, WA; Submission type: D; Filing date: 2026-07-28; Industry Group: Biotechnology; Date of First Sale: 2026-07-21; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 10492778; Total Amount Sold: 10492778; Federal exemptions: 06b”
| Jul 21, 2026 | SEC Form D ↗ |
| InterAct Therapeutics | SEC Form D Debt / note · Form D reports $250K sold of $2M offeredSource quote- Filed Jul 21, 2026 · SEC Form D ↗
“Name of Issuer: InterAct Therapeutics, Inc.; CIK: 2107143; Address: Dallas, TX; Submission type: D; Filing date: 2026-07-21; Industry Group: Other Health Care; Date of First Sale: 2026-07-20; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 2000000; Total Amount Sold: 250000; Federal exemptions: 06b”
| Jul 20, 2026 | SEC Form D ↗ |
| FluidForm Inc. Filed as FluidForm Bio, Inc. | SEC Form D Equity · Form D reports $1.7M sold of $3M offeredSource quote- Filed Aug 27, 2026 · SEC Form D ↗
“Name of Issuer: FluidForm Bio, Inc.; CIK: 2062460; Address: Waltham, MA; Submission type: D; Filing date: 2026-08-27; Industry Group: Biotechnology; Date of First Sale: 2026-07-16; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 1703371; Federal exemptions: 06b”
| Jul 16, 2026 | SEC Form D ↗ |
| Georgiamune | SEC Form D Equity · Form D reports $92.69M sold of $131.85M offeredSource quote- Filed Aug 17, 2026 · SEC Form D ↗
“Name of Issuer: Georgiamune, Inc.; CIK: 2148230; Address: Gaithersburg, MD; Submission type: D; Filing date: 2026-08-17; Industry Group: Biotechnology; Date of First Sale: 2026-07-16; Types of Securities Offered: Equity, Other (Series B Preferred Stock); Business combination transaction: false; Total Offering Amount: 131852011; Total Amount Sold: 92692709; Federal exemptions: 06b”
| Jul 16, 2026 | SEC Form D ↗ |
| Ratio Therapeutics | SEC Form D Equity · Form D reports $70M soldSource quote- Filed Jul 31, 2026 · SEC Form D ↗
“Name of Issuer: Ratio Therapeutics, Inc.; CIK: 2004792; Address: Boston, MA; Submission type: D; Filing date: 2026-07-31; Industry Group: Pharmaceuticals; Date of First Sale: 2026-07-16; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 69999974; Total Amount Sold: 69999974; Federal exemptions: 06b”
| Jul 16, 2026 | SEC Form D ↗ |
| Genomenon | SEC Form D Equity · Form D reports $6.03M sold of $10M offeredSource quote- Filed Jul 30, 2026 · SEC Form D ↗
“Name of Issuer: Genomenon, Inc.; CIK: 1650557; Address: Ann Arbor, MI; Submission type: D; Filing date: 2026-07-30; Industry Group: Biotechnology; Date of First Sale: 2026-07-15; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 6025002; Federal exemptions: 06b”
| Jul 15, 2026 | SEC Form D ↗ |
| ALZpath, Inc. | SEC Form D Equity · Form D reports $8.41M sold of $10.41M offeredSource quote- Filed Jul 21, 2026 · SEC Form D ↗
“Name of Issuer: ALZpath, Inc.; CIK: 2145244; Address: Carlsbad, CA; Submission type: D; Filing date: 2026-07-21; Industry Group: Biotechnology; Date of First Sale: 2026-07-14; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 10411219; Total Amount Sold: 8411219; Federal exemptions: 06b”
| Jul 14, 2026 | SEC Form D ↗ |
| Sonavex | SEC Form D Equity · Form D reports $3.1M sold of $15M offeredSource quote- Filed Jul 28, 2026 · SEC Form D ↗
“Name of Issuer: Sonavex, Inc.; CIK: 1645892; Address: city not listed;DONNELL STREET, BALTIMORE, MARYLAND; Submission type: D; Filing date: 2026-07-28; Industry Group: Biotechnology; Date of First Sale: 2026-07-13; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 15000000; Total Amount Sold: 3102995; Federal exemptions: 06b”
| Jul 13, 2026 | SEC Form D ↗ |
| Cooler Heads Care Inc. | SEC Form D Equity · Form D reports $3.27M sold of $6M offeredSource quote- Filed Jul 23, 2026 · SEC Form D ↗
“Name of Issuer: COOLER HEADS CARE, INC.; CIK: 1972845; Address: San Diego, CA; Submission type: D; Filing date: 2026-07-23; Industry Group: Other Health Care; Date of First Sale: 2026-07-10; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 5999928; Total Amount Sold: 3267467; Federal exemptions: 06b”
| Jul 10, 2026 | SEC Form D ↗ |
| Pelva Health Corporation | SEC Form D SAFE · Form D reports $30K sold of $2M offeredSource quote- Filed Aug 7, 2026 · SEC Form D ↗
“Name of Issuer: Pelva Health Corp; CIK: 2008160; Address: Edina, MN; Submission type: D; Filing date: 2026-08-07; Industry Group: Other Health Care; Date of First Sale: 2026-07-09; Types of Securities Offered: Other (SAFE instrument); Business combination transaction: false; Total Offering Amount: 2000000; Total Amount Sold: 30000; Federal exemptions: 06b”
| Jul 9, 2026 | SEC Form D ↗ |
| TECLens | SEC Form D Debt / note · Form D reports $5.23M sold of $10.23M offeredSource quote- Filed Jul 24, 2026 · SEC Form D ↗
“Name of Issuer: TECLens, Inc.; CIK: 1708436; Address: Stamford, CT; Submission type: D; Filing date: 2026-07-24; Industry Group: Other Health Care; Date of First Sale: 2026-07-09; Types of Securities Offered: Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 10230000; Total Amount Sold: 5230000; Federal exemptions: 06b”
| Jul 9, 2026 | SEC Form D ↗ |
| TYBR Health | SEC Form D Equity · Form D reports $14.35M sold of $30M offeredSource quote- Filed Jul 22, 2026 · SEC Form D ↗
“Name of Issuer: TYBR Health, Inc.; CIK: 1835188; Address: Houston, TX; Submission type: D; Filing date: 2026-07-22; Industry Group: Biotechnology; Date of First Sale: 2026-07-09; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 30000000; Total Amount Sold: 14354342; Federal exemptions: 06b”
| Jul 9, 2026 | SEC Form D ↗ |
| Silo Pharma | SEC Form D Equity · Form D reports $4M soldSource quote- Filed Jul 14, 2026 · SEC Form D ↗
“Name of Issuer: Silo Pharma, Inc.; CIK: 1514183; Address: Sarasota, FL; Submission type: D; Filing date: 2026-07-14; Industry Group: Pharmaceuticals; Date of First Sale: 2026-07-09; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 4000015; Total Amount Sold: 4000015; Federal exemptions: 06b”
| Jul 9, 2026 | SEC Form D ↗ |
| Hexamer Therapeutics | SEC Form D Equity · Form D reports $500K sold of $2.5M offeredSource quote- Filed Sep 15, 2026 · SEC Form D ↗
“Name of Issuer: Hexamer Therapeutics, Inc; CIK: 1797915; Address: Pullman, WA; Submission type: D; Filing date: 2026-09-15; Industry Group: Biotechnology; Date of First Sale: 2026-07-07; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 2500000; Total Amount Sold: 500000; Federal exemptions: 06b”
| Jul 7, 2026 | SEC Form D ↗ |
| Lifeward | SEC Form D Equity + debt/notes · Form D reports $11.16M sold (offering size open-ended)Source quote- Filed Jul 8, 2026 · SEC Form D ↗
“Name of Issuer: Lifeward Ltd.; CIK: 1607962; Address: Hudson, MA; Submission type: D; Filing date: 2026-07-08; Industry Group: Biotechnology; Date of First Sale: 2026-07-06; Types of Securities Offered: Equity, Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 11160000; Federal exemptions: 06b”
| Jul 6, 2026 | SEC Form D ↗ |
| Shape Memory Medical | SEC Form D Debt / note · Form D reports $6.91M sold of $10M offeredSource quote- Filed Jul 16, 2026 · amended Jul 31, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: Shape Memory Medical Inc.; CIK: 1630786; Address: San Jose, CA; Submission type: D/A; Filing date: 2026-07-31; Industry Group: Other Health Care; Date of First Sale: 2026-07-02; Types of Securities Offered: Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 6912400; Federal exemptions: 06b”
| Jul 2, 2026 | SEC Form D/A ↗ |
| Amlogenyx | SEC Form D Debt / note · Form D reports $10M sold of $20M offeredSource quote- Filed Jul 9, 2026 · SEC Form D ↗
“Name of Issuer: Amlogenyx Inc.; CIK: 2031988; Address: Novato, CA; Submission type: D; Filing date: 2026-07-09; Industry Group: Biotechnology; Date of First Sale: 2026-07-01; Types of Securities Offered: Other (Convertible Promissory Notes and equity securities issuable upon conversion thereof); Business combination transaction: false; Total Offering Amount: 20000000; Total Amount Sold: 10000000; Federal exemptions: 06b”
| Jul 1, 2026 | SEC Form D ↗ |
| Merlin Biotech Inc. | SEC Form D Debt / note · Form D reports $50K soldSource quote- Filed Aug 11, 2026 · SEC Form D ↗
“Name of Issuer: Merlin Biotech, Inc.; CIK: 2149714; Address: Doylestown, PA; Submission type: D; Filing date: 2026-08-11; Industry Group: Biotechnology; Date of First Sale: 2026-06-30; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 50000; Total Amount Sold: 50000; Federal exemptions: 06b”
| Jun 30, 2026 | SEC Form D ↗ |
| 410 Medical | SEC Form D Equity · Form D reports $10.32M sold of $12M offeredSource quote- Filed Jul 15, 2026 · SEC Form D ↗
“Name of Issuer: 410 Medical, Inc.; CIK: 1630050; Address: Durham, NC; Submission type: D; Filing date: 2026-07-15; Industry Group: Other Health Care; Date of First Sale: 2026-06-30; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 12000000; Total Amount Sold: 10323798; Federal exemptions: 06b”
| Jun 30, 2026 | SEC Form D ↗ |
| ImmunoVec | SEC Form D Equity + debt/notes · Form D reports $12.71M sold of $15M offeredSource quote- Filed Jul 14, 2026 · SEC Form D ↗
“Name of Issuer: ImmunoVec, Inc.; CIK: 1914272; Address: Los Angeles, CA; Submission type: D; Filing date: 2026-07-14; Industry Group: Other Technology; Date of First Sale: 2026-06-29; Types of Securities Offered: Equity, Security to be acquired, Other (Preferred Stock and Common Stock issuable upon conversion thereof. Total Offering Amount and Total Amount Sold include conversion of the previously issued convertible securities.); Business combination transaction: false; Total Offering Amount: 14999944; Total Amount Sold: 12705822; Federal exemptions: 06b”
| Jun 29, 2026 | SEC Form D ↗ |
| Vantis Vascular | SEC Form D Equity · Form D reports $18.64M sold of $21.5M offeredSource quote- Filed Jul 10, 2026 · SEC Form D ↗
“Name of Issuer: Vantis Vascular, Inc.; CIK: 1761882; Address: San Jose, CA; Submission type: D; Filing date: 2026-07-10; Industry Group: Other; Date of First Sale: 2026-06-26; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 21500000; Total Amount Sold: 18639500; Federal exemptions: 06b”
| Jun 26, 2026 | SEC Form D ↗ |
| Cellular Logistics | SEC Form D Debt / note · Form D reports $50K sold of $100K offeredSource quote- Filed Jul 15, 2026 · SEC Form D ↗
“Name of Issuer: Cellular Logistics, Inc.; CIK: 1688621; Address: Madison, WI; Submission type: D; Filing date: 2026-07-15; Industry Group: Biotechnology; Date of First Sale: 2026-06-25; Types of Securities Offered: Debt, Other (convertible promissory note); Business combination transaction: false; Total Offering Amount: 100000; Total Amount Sold: 50000; Federal exemptions: 06b”
| Jun 25, 2026 | SEC Form D ↗ |
| Akadeum Life Sciences | SEC Form D Equity · Form D reports $2.13M sold of $3.43M offeredSource quote- Filed Jul 9, 2026 · SEC Form D ↗
“Name of Issuer: AKADEUM LIFE SCIENCES, INC.; CIK: 1622872; Address: Ann Arbor, MI; Submission type: D; Filing date: 2026-07-09; Industry Group: Biotechnology; Date of First Sale: 2026-06-25; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 3427230; Total Amount Sold: 2130557; Federal exemptions: 06b”
| Jun 25, 2026 | SEC Form D ↗ |
| InnSight Technology | SEC Form D Equity · Form D reports $1.35M sold of $3M offeredSource quote- Filed Jul 13, 2026 · SEC Form D ↗
“Name of Issuer: InnSight Technology, Inc.; CIK: 1956287; Address: Pittsburgh, PA; Submission type: D; Filing date: 2026-07-13; Industry Group: Other Health Care; Date of First Sale: 2026-06-23; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 1350000; Federal exemptions: 06b”
| Jun 23, 2026 | SEC Form D ↗ |
| Rapalogix Health | SEC Form D Equity · Form D reports $19.11M sold of $25M offeredSource quote- Filed Jun 26, 2026 · SEC Form D ↗
“Name of Issuer: Rapalogix Health, Inc.; CIK: 2008372; Address: Carlsbad, CA; Submission type: D; Filing date: 2026-06-26; Industry Group: Biotechnology; Date of First Sale: 2026-06-22; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 24999999; Total Amount Sold: 19112746; Federal exemptions: 06b”
| Jun 22, 2026 | SEC Form D ↗ |
| Pneuma Respiratory | SEC Form D Equity · Form D reports $3.57M sold (offering size open-ended)Source quote- Filed Jul 1, 2026 · SEC Form D ↗
“Name of Issuer: Pneuma Respiratory, Inc.; CIK: 1701794; Address: Boone, NC; Submission type: D; Filing date: 2026-07-01; Industry Group: Pharmaceuticals; Date of First Sale: 2026-06-18; Types of Securities Offered: Equity, Option/warrant, Other (Common Stock and Warrants to Purchase Common Stock); Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 3570115; Federal exemptions: 06b”
| Jun 18, 2026 | SEC Form D ↗ |
| CYduct Diagnostics | SEC Form D Equity · Form D reports $1.96M soldSource quote- Filed Jul 2, 2026 · SEC Form D ↗
“Name of Issuer: CYduct Diagnostics, Inc.; CIK: 1388994; Address: Westport, CT; Submission type: D; Filing date: 2026-07-02; Industry Group: Biotechnology; Date of First Sale: 2026-06-15; Types of Securities Offered: Equity, Other (Common Stock); Business combination transaction: false; Total Offering Amount: 1961000; Total Amount Sold: 1961000; Federal exemptions: 06b”
| Jun 15, 2026 | SEC Form D ↗ |
| Qlaris Bio | SEC Form D Debt / note · Form D reports $3.95M soldSource quote- Filed Jun 17, 2026 · SEC Form D ↗
“Name of Issuer: Qlaris Bio, Inc.; CIK: 1786717; Address: Dedham, MA; Submission type: D; Filing date: 2026-06-17; Industry Group: Biotechnology; Date of First Sale: 2026-06-12; Types of Securities Offered: Debt, Option/warrant, Other (Convertible Promissory Notes); Business combination transaction: false; Total Offering Amount: 3946659; Total Amount Sold: 3946659; Federal exemptions: 06b”
| Jun 12, 2026 | SEC Form D ↗ |
| TETmedical | SEC Form D Equity · Form D reports $3.53M sold of $9.81M offeredSource quote- Filed Jun 24, 2026 · SEC Form D ↗
“Name of Issuer: TETmedical, Inc.; CIK: 1980705; Address: Fair Haven, NJ; Submission type: D; Filing date: 2026-06-24; Industry Group: Biotechnology; Date of First Sale: 2026-06-12; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 9812108; Total Amount Sold: 3533611; Federal exemptions: 06b”
| Jun 12, 2026 | SEC Form D ↗ |
| NeOnc Technologies Filed as NEONC TECHNOLOGIES HOLDINGS, INC. | SEC Form D Equity · Form D reports $5M soldSource quote- Filed Jun 25, 2026 · SEC Form D ↗
“Name of Issuer: NEONC TECHNOLOGIES HOLDINGS, INC.; CIK: 1979414; Address: Calabasas, CA; Submission type: D; Filing date: 2026-06-25; Industry Group: Biotechnology; Date of First Sale: 2026-06-10; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 5000000; Total Amount Sold: 5000000; Federal exemptions: 06b”
| Jun 10, 2026 | SEC Form D ↗ |
| CND Life Sciences | SEC Form D Debt / note · Form D reports $6.32M soldSource quote- Filed Jun 16, 2026 · amended Aug 3, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: CND Life Sciences, Inc.; CIK: 1841099; Address: Scottsdale, AZ; Submission type: D/A; Filing date: 2026-08-03; Industry Group: Biotechnology; Date of First Sale: 2026-06-09; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 6316514; Total Amount Sold: 6316514; Federal exemptions: 06b”
| Jun 9, 2026 | SEC Form D/A ↗ |
| CeleCor Therapeutics | SEC Form D Equity · Form D reports $11.86M sold of $15M offeredSource quote- Filed Jul 9, 2026 · SEC Form D ↗
“Name of Issuer: CeleCor Therapeutics, Inc.; CIK: 1705381; Address: Del Mar, CA; Submission type: D; Filing date: 2026-07-09; Industry Group: Pharmaceuticals; Date of First Sale: 2026-06-09; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 15000000; Total Amount Sold: 11856325; Federal exemptions: 06b”
| Jun 9, 2026 | SEC Form D ↗ |
| Reservoir Neuroscience | SEC Form D Equity · Form D reports $3M sold of $8M offeredSource quote- Filed Jun 17, 2026 · SEC Form D ↗
“Name of Issuer: Reservoir Neuroscience, Inc.; CIK: 1878332; Address: San Francisco, CA; Submission type: D; Filing date: 2026-06-17; Industry Group: Biotechnology; Date of First Sale: 2026-06-08; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 8000000; Total Amount Sold: 2999999; Federal exemptions: 06b”
| Jun 8, 2026 | SEC Form D ↗ |
| CSA Medical | SEC Form D Equity · Form D reports $2.91M sold of $11.22M offeredSource quote- Filed Jul 23, 2026 · SEC Form D ↗
“Name of Issuer: CSA Medical, Inc.; CIK: 1403000; Address: Lexington, MA; Submission type: D; Filing date: 2026-07-23; Industry Group: Other; Date of First Sale: 2026-06-08; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 11217710; Total Amount Sold: 2908295; Federal exemptions: 06b”
| Jun 8, 2026 | SEC Form D ↗ |
| Aspira Women's Health | SEC Form D Equity · Form D reports $1.49M soldSource quote- Filed Jun 22, 2026 · SEC Form D ↗
“Name of Issuer: Aspira Women's Health Inc.; CIK: 926617; Address: Austin, TX; Submission type: D; Filing date: 2026-06-22; Industry Group: Biotechnology; Date of First Sale: 2026-06-05; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 1485000; Total Amount Sold: 1485000; Federal exemptions: 06b”
| Jun 5, 2026 | SEC Form D ↗ |
| EndoSound | SEC Form D Equity · Form D reports $250K sold of $5M offeredSource quote- Filed Jun 17, 2026 · SEC Form D ↗
“Name of Issuer: EndoSound, Inc.; CIK: 1850978; Address: Portland, OR; Submission type: D; Filing date: 2026-06-17; Industry Group: Other Health Care; Date of First Sale: 2026-06-05; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 5000000; Total Amount Sold: 250000; Federal exemptions: 06b”
| Jun 5, 2026 | SEC Form D ↗ |
| Nuclein | SEC Form D Debt / note · Form D reports $9.25M sold of $16.11M offeredSource quote- Filed Jun 22, 2026 · amended Aug 14, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: Nuclein, LLC; CIK: 1787352; Address: Austin, TX; Submission type: D/A; Filing date: 2026-08-14; Industry Group: Biotechnology; Date of First Sale: 2026-06-04; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 16114842; Total Amount Sold: 9253488; Federal exemptions: 06b”
| Jun 4, 2026 | SEC Form D/A ↗ |
| Tolerance Bio | SEC Form D Equity · Form D reports $15.1M sold (offering size open-ended)Source quote- Filed Jun 18, 2026 · SEC Form D ↗
“Name of Issuer: Tolerance Bio Inc.; CIK: 2075488; Address: Philadelphia, PA; Submission type: D; Filing date: 2026-06-18; Industry Group: Biotechnology; Date of First Sale: 2026-06-03; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 15101584; Federal exemptions: 06b”
| Jun 3, 2026 | SEC Form D ↗ |
| Channel Robotics | SEC Form D Equity · Form D reports $4.72M soldSource quote- Filed Jun 3, 2026 · SEC Form D ↗
“Name of Issuer: CHANNEL ROBOTICS, INC.; CIK: 2045979; Address: Del Mar, CA; Submission type: D; Filing date: 2026-06-03; Industry Group: Other Health Care; Date of First Sale: 2026-06-02; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 4718586; Total Amount Sold: 4718586; Federal exemptions: 06b”
| Jun 2, 2026 | SEC Form D ↗ |
| Thiogenesis Therapeutics, Inc. | SEC Form D Equity · Form D reports $29K soldSource quote- Filed Jun 9, 2026 · SEC Form D ↗
“Name of Issuer: Thiogenesis Therapeutics, Corp.; CIK: 1877778; Address: Ontario, Canada; Submission type: D; Filing date: 2026-06-09; Industry Group: Biotechnology; Date of First Sale: 2026-06-01; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 28964; Total Amount Sold: 28964; Federal exemptions: 06b”
| Jun 1, 2026 | SEC Form D ↗ |
| Contraline | SEC Form D Equity · Form D reports $55.8M sold of $115.93M offeredSource quote- Filed Jun 10, 2026 · SEC Form D ↗
“Name of Issuer: Contraline, Inc.; CIK: 1818752; Address: Charlottesville, VA; Submission type: D; Filing date: 2026-06-10; Industry Group: Biotechnology; Date of First Sale: 2026-05-29; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 115929658; Total Amount Sold: 55804741; Federal exemptions: 06b”
| May 29, 2026 | SEC Form D ↗ |
| Human Continuum | SEC Form D Equity · Form D reports $722K soldSource quote- Filed Jun 5, 2026 · SEC Form D ↗
“Name of Issuer: Human Continuum Inc.; CIK: 2138781; Address: Jupiter, FL; Submission type: D; Filing date: 2026-06-05; Industry Group: Other; Date of First Sale: 2026-05-29; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 722500; Total Amount Sold: 722500; Federal exemptions: 06b”
| May 29, 2026 | SEC Form D ↗ |
| Medicenna Therapeutics, Inc. | SEC Form D Equity · Form D reports $253K sold of $2.34M offeredSource quote- Filed Jul 6, 2026 · SEC Form D ↗
“Name of Issuer: Medicenna Therapeutics Corp.; CIK: 1807983; Address: Ontario, Canada; Submission type: D; Filing date: 2026-07-06; Industry Group: Biotechnology; Date of First Sale: 2026-05-28; Types of Securities Offered: Equity, Option/warrant, Security to be acquired, Other (Each Unit is comprised of 1 common share and 1/2 of 1 common share purchase warrant. Each Warrant entitles the holder thereof to purchase one additional Share at an exercise price of CDN$0.65 per Share for a period of 3 years following May 28, 2026.); Business combination transaction: false; Total Offering Amount: 2343400; Total Amount Sold: 253458; Federal exemptions: 06b”
| May 28, 2026 | SEC Form D ↗ |
| Anodyne Nanotech | SEC Form D Equity · Form D reports $12.6M sold of $17.26M offeredSource quote- Filed Jun 11, 2026 · SEC Form D ↗
“Name of Issuer: Anodyne Nanotech, Inc.; CIK: 1818572; Address: Boston, MA; Submission type: D; Filing date: 2026-06-11; Industry Group: Other Health Care; Date of First Sale: 2026-05-27; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 17259023; Total Amount Sold: 12597058; Federal exemptions: 06b”
| May 27, 2026 | SEC Form D ↗ |
| Spine BioPharma | SEC Form D Equity · Form D reports $385K sold of $8.5M offeredSource quote- Filed Jun 5, 2026 · SEC Form D ↗
“Name of Issuer: Spine BioPharma, Inc.; CIK: 1852647; Address: New York, NY; Submission type: D; Filing date: 2026-06-05; Industry Group: Pharmaceuticals; Date of First Sale: 2026-05-22; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 8500000; Total Amount Sold: 384798; Federal exemptions: 06b”
| May 22, 2026 | SEC Form D ↗ |
| Antlia Bioscience, Inc. | SEC Form D Equity · Form D reports $6M sold of $20M offeredSource quote- Filed Jun 5, 2026 · SEC Form D ↗
“Name of Issuer: Antlia Bioscience, Inc.; CIK: 1829522; Address: Encinitas, CA; Submission type: D; Filing date: 2026-06-05; Industry Group: Biotechnology; Date of First Sale: 2026-05-22; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 20000000; Total Amount Sold: 6000000; Federal exemptions: 06b”
| May 22, 2026 | SEC Form D ↗ |
| Optimeos Life Sciences, Inc. | SEC Form D Debt / note · Form D reports $1M sold of $2M offeredSource quote- Filed Jun 3, 2026 · SEC Form D ↗
“Name of Issuer: Optimeos Life Sciences, Inc.; CIK: 1819114; Address: Princeton, NJ; Submission type: D; Filing date: 2026-06-03; Industry Group: Biotechnology; Date of First Sale: 2026-05-22; Types of Securities Offered: Debt, Option/warrant; Business combination transaction: false; Total Offering Amount: 2000000; Total Amount Sold: 1000000; Federal exemptions: 06b”
| May 22, 2026 | SEC Form D ↗ |
| MaxQ Medical | SEC Form D Equity · Form D reports $31.53M soldSource quote- Filed Aug 19, 2026 · SEC Form D ↗
“Name of Issuer: MaxQ Medical Inc.; CIK: 2027191; Address: Sunnyvale, CA; Submission type: D; Filing date: 2026-08-19; Industry Group: Manufacturing; Date of First Sale: 2026-05-22; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 31529997; Total Amount Sold: 31529997; Federal exemptions: 06b, 4a5”
| May 22, 2026 | SEC Form D ↗ |
| Cerium Pharmaceuticals | SEC Form D Equity · Form D reports $750K sold of $2.54M offeredSource quote- Filed Aug 6, 2026 · SEC Form D ↗
“Name of Issuer: Cerium Pharmaceuticals, Inc.; CIK: 1677995; Address: Gaithersburg, MD; Submission type: D; Filing date: 2026-08-06; Industry Group: Pharmaceuticals; Date of First Sale: 2026-05-22; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 2544000; Total Amount Sold: 750000; Federal exemptions: 06b”
| May 22, 2026 | SEC Form D ↗ |
| Infinant Health | SEC Form D Equity · Form D reports $39.25M sold of $118.23M offeredSource quote- Filed Jun 8, 2026 · SEC Form D ↗
“Name of Issuer: Infinant Health, Inc.; CIK: 2139235; Address: Sacramento, CA; Submission type: D; Filing date: 2026-06-08; Industry Group: Other Health Care; Date of First Sale: 2026-05-21; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 118230513; Total Amount Sold: 39247552; Federal exemptions: 06b”
| May 21, 2026 | SEC Form D ↗ |
| HCW Biologics | SEC Form D Equity · Form D reports $4M soldSource quote- Filed Jun 8, 2026 · SEC Form D ↗
“Name of Issuer: HCW Biologics Inc.; CIK: 1828673; Address: Miramar, FL; Submission type: D; Filing date: 2026-06-08; Industry Group: Biotechnology; Date of First Sale: 2026-05-21; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 4000000; Total Amount Sold: 4000000; Federal exemptions: 06b”
| May 21, 2026 | SEC Form D ↗ |
| Cognos Therapeutics | SEC Form D Debt / note · Form D reports $250K sold of $2M offeredSource quote- Filed Jul 2, 2026 · SEC Form D ↗
“Name of Issuer: Cognos Therapeutics Inc; CIK: 1651490; Address: Inglewood, CA; Submission type: D; Filing date: 2026-07-02; Industry Group: Biotechnology; Date of First Sale: 2026-05-21; Types of Securities Offered: Debt, Security to be acquired; Business combination transaction: false; Total Offering Amount: 2000000; Total Amount Sold: 250000; Federal exemptions: 06b”
| May 21, 2026 | SEC Form D ↗ |
| Senti Biosciences Filed as Senti Biosciences Holdings, Inc. | SEC Form D Debt / note · Form D reports $10M sold of $40M offeredSource quote- Filed Jun 4, 2026 · SEC Form D ↗
“Name of Issuer: Senti Biosciences Holdings, Inc.; CIK: 1854270; Address: South San Francisco, CA; Submission type: D; Filing date: 2026-06-04; Industry Group: Biotechnology; Date of First Sale: 2026-05-20; Types of Securities Offered: Debt, Other (Guarantee); Business combination transaction: false; Total Offering Amount: 40000000; Total Amount Sold: 10000000; Federal exemptions: 06b”
| May 20, 2026 | SEC Form D ↗ |
| Biolexis Therapeutics | SEC Form D Debt / note · Form D reports $1.6M sold of $12M offeredSource quote- Filed Jun 3, 2026 · SEC Form D ↗
“Name of Issuer: Biolexis Therapeutics Inc.; CIK: 1914060; Address: Lehi, UT; Submission type: D; Filing date: 2026-06-03; Industry Group: Biotechnology; Date of First Sale: 2026-05-20; Types of Securities Offered: Other (Convertible Promissory Notes); Business combination transaction: false; Total Offering Amount: 12000000; Total Amount Sold: 1600000; Federal exemptions: 06b”
| May 20, 2026 | SEC Form D ↗ |
| ViCardia Therapeutics | SEC Form D Equity · Form D reports $700K soldSource quote- Filed May 21, 2026 · SEC Form D ↗
“Name of Issuer: ViCardia Therapeutics, Inc.; CIK: 2135564; Address: San Francisco, CA; Submission type: D; Filing date: 2026-05-21; Industry Group: Biotechnology; Date of First Sale: 2026-05-19; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 700000; Total Amount Sold: 700000; Federal exemptions: 06b”
| May 19, 2026 | SEC Form D ↗ |
| Quince Therapeutics | SEC Form D Equity · Form D reports $114.72M sold of $186.42M offeredSource quote- Filed Jun 11, 2026 · SEC Form D ↗
“Name of Issuer: Quince Therapeutics, Inc.; CIK: 1662774; Address: South San Francisco, CA; Submission type: D; Filing date: 2026-06-11; Industry Group: Biotechnology; Date of First Sale: 2026-05-18; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 186422679; Total Amount Sold: 114720542; Federal exemptions: 06b”
| May 18, 2026 | SEC Form D ↗ |
| Portal Biotechnologies | SEC Form D Equity · Form D reports $9M soldSource quote- Filed May 29, 2026 · SEC Form D ↗
“Name of Issuer: Portal Biotechnologies, Inc.; CIK: 2049466; Address: Arlington, MA; Submission type: D; Filing date: 2026-05-29; Industry Group: Biotechnology; Date of First Sale: 2026-05-15; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 8999999; Total Amount Sold: 8999999; Federal exemptions: 06b”
| May 15, 2026 | SEC Form D ↗ |
| MBQ Pharma | SEC Form D Equity · Form D reports $991K sold (offering size open-ended)Source quote- Filed Aug 14, 2026 · SEC Form D ↗
“Name of Issuer: MBQ PHARMA INC.; CIK: 2148840; Address: San Juan, PR; Submission type: D; Filing date: 2026-08-14; Industry Group: Pharmaceuticals; Date of First Sale: 2026-05-15; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 991038; Federal exemptions: 06b”
| May 15, 2026 | SEC Form D ↗ |
| Imaginostics | SEC Form D SAFE · Form D reports $40K sold (offering size open-ended)Source quote- Filed May 29, 2026 · SEC Form D ↗
“Name of Issuer: IMAGINOSTICS, INC.; CIK: 2122464; Address: Orlando, FL; Submission type: D; Filing date: 2026-05-29; Industry Group: Biotechnology; Date of First Sale: 2026-05-14; Types of Securities Offered: Equity, Option/warrant, Security to be acquired, Other (These securities are Simple Agreements for Future Equity (SAFEs), which are convertible into equity securities of the issuer,typically preferred stock,upon the occurrence of specified triggering events including future financingroundS.); Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 40000; Federal exemptions: 06b”
| May 14, 2026 | SEC Form D ↗ |
| Reprise Biomedical | SEC Form D Equity · Form D reports $9.25M sold of $10M offeredSource quote- Filed May 21, 2026 · amended Jul 1, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: Reprise Biomedical, Inc.; CIK: 1782236; Address: Plymouth, MN; Submission type: D/A; Filing date: 2026-07-01; Industry Group: Biotechnology; Date of First Sale: 2026-05-14; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 9246100; Federal exemptions: 06b”
| May 14, 2026 | SEC Form D/A ↗ |
| Oncosynergy, Inc. | SEC Form D Equity · Form D reports $6.61M sold of $8.21M offeredSource quote- Filed May 26, 2026 · SEC Form D ↗
“Name of Issuer: ONCOSYNERGY, INC.; CIK: 1556747; Address: Stamford, CT; Submission type: D; Filing date: 2026-05-26; Industry Group: Biotechnology; Date of First Sale: 2026-05-11; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 8208830; Total Amount Sold: 6608832; Federal exemptions: 06b”
| May 11, 2026 | SEC Form D ↗ |
| Sentrimed | SEC Form D Debt / note · Form D reports $250K sold of $1M offeredSource quote- Filed May 13, 2026 · SEC Form D ↗
“Name of Issuer: Sentrimed, Inc.; CIK: 2014313; Address: Mullica Hill, NJ; Submission type: D; Filing date: 2026-05-13; Industry Group: Biotechnology; Date of First Sale: 2026-05-08; Types of Securities Offered: Debt, Security to be acquired; Business combination transaction: false; Total Offering Amount: 1000000; Total Amount Sold: 250000; Federal exemptions: 06b”
| May 8, 2026 | SEC Form D ↗ |
| GT Medical Technologies | SEC Form D Equity · Form D reports $50.06M sold of $100.06M offeredSource quote- Filed Jul 22, 2026 · SEC Form D ↗
“Name of Issuer: GT MEDICAL TECHNOLOGIES, INC.; CIK: 1723008; Address: Tempe, AZ; Submission type: D; Filing date: 2026-07-22; Industry Group: Other Health Care; Date of First Sale: 2026-05-08; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 100056698; Total Amount Sold: 50056676; Federal exemptions: 06b”
| May 8, 2026 | SEC Form D ↗ |
| Illuminare Biotechnologies | SEC Form D Equity · Form D reports $3.65M sold of $4M offeredSource quote- Filed Jun 4, 2026 · SEC Form D ↗
“Name of Issuer: Illuminare Biotechnologies Inc; CIK: 1701523; Address: Brooklyn, NY; Submission type: D; Filing date: 2026-06-04; Industry Group: Biotechnology; Date of First Sale: 2026-05-07; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 4000000; Total Amount Sold: 3650000; Federal exemptions: 06b”
| May 7, 2026 | SEC Form D ↗ |
| Remedium Bio | SEC Form D Equity · Form D reports $1.5M sold of $10M offeredSource quote- Filed May 18, 2026 · SEC Form D ↗
“Name of Issuer: Remedium Bio Inc.; CIK: 1892414; Address: Needham, MA; Submission type: D; Filing date: 2026-05-18; Industry Group: Biotechnology; Date of First Sale: 2026-05-06; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 1500000; Federal exemptions: 06b”
| May 6, 2026 | SEC Form D ↗ |
| Allyx Therapeutics Inc. | SEC Form D Equity · Form D reports $26.43M sold of $30M offeredSource quote- Filed May 11, 2026 · SEC Form D ↗
“Name of Issuer: Allyx Therapeutics, Inc.; CIK: 1865257; Address: New Haven, CT; Submission type: D; Filing date: 2026-05-11; Industry Group: Biotechnology; Date of First Sale: 2026-05-04; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 29999999; Total Amount Sold: 26427730; Federal exemptions: 06b”
| May 4, 2026 | SEC Form D ↗ |
| CNS Pharmaceuticals | SEC Form D Equity · Form D reports $22.52M soldSource quote- Filed May 19, 2026 · SEC Form D ↗
“Name of Issuer: CNS Pharmaceuticals, Inc.; CIK: 1729427; Address: Houston, TX; Submission type: D; Filing date: 2026-05-19; Industry Group: Pharmaceuticals; Date of First Sale: 2026-05-04; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 22525000; Total Amount Sold: 22525000; Federal exemptions: 06b”
| May 4, 2026 | SEC Form D ↗ |
| Miach Orthopaedics | SEC Form D Debt / note · Form D reports $6.5M soldSource quote- Filed May 7, 2026 · SEC Form D ↗
“Name of Issuer: Miach Orthopaedics Inc.; CIK: 1964453; Address: Westborough, MA; Submission type: D; Filing date: 2026-05-07; Industry Group: Other Health Care; Date of First Sale: 2026-05-01; Types of Securities Offered: Debt, Option/warrant; Business combination transaction: false; Total Offering Amount: 6500000; Total Amount Sold: 6500000; Federal exemptions: 06b”
| May 1, 2026 | SEC Form D ↗ |
| Galaxy Diagnostics | SEC Form D Equity · Form D reports $3.02M sold of $5.7M offeredSource quote- Filed Jun 3, 2026 · SEC Form D ↗
“Name of Issuer: Galaxy Diagnostics, Inc.; CIK: 1462444; Address: Durham, NC; Submission type: D; Filing date: 2026-06-03; Industry Group: Biotechnology; Date of First Sale: 2026-05-01; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 5699460; Total Amount Sold: 3019645; Federal exemptions: 06b”
| May 1, 2026 | SEC Form D ↗ |
| PROTECT3D Inc. | SEC Form D Debt / note · Form D reports $845K sold of $1M offeredSource quote- Filed Jun 4, 2026 · SEC Form D ↗
“Name of Issuer: Protect3d, Inc.; CIK: 1792316; Address: Durham, NC; Submission type: D; Filing date: 2026-06-04; Industry Group: Other Health Care; Date of First Sale: 2026-04-30; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 1000000; Total Amount Sold: 845000; Federal exemptions: 06b”
| Apr 30, 2026 | SEC Form D ↗ |
| Solius Filed as Solius Labs, Inc. | SEC Form D Equity · Form D reports $3.5M sold of $17.91M offeredSource quote- Filed May 14, 2026 · SEC Form D ↗
“Name of Issuer: Solius Labs, Inc.; CIK: 1537914; Address: Bainbridge Island, WA; Submission type: D; Filing date: 2026-05-14; Industry Group: Other Health Care; Date of First Sale: 2026-04-29; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 17911021; Total Amount Sold: 3500000; Federal exemptions: 06b”
| Apr 29, 2026 | SEC Form D ↗ |
| Eyenuk | SEC Form D Equity · Form D reports $5.61M sold of $5.65M offeredSource quote- Filed Jun 22, 2026 · SEC Form D ↗
“Name of Issuer: Eyenuk, Inc.; CIK: 1679996; Address: Woodland Hills, CA; Submission type: D; Filing date: 2026-06-22; Industry Group: Other Health Care; Date of First Sale: 2026-04-28; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 5648246; Total Amount Sold: 5607046; Federal exemptions: 06b”
| Apr 28, 2026 | SEC Form D ↗ |
| Pagari Life Science | SEC Form D Equity · Form D reports $97K sold of $300K offeredSource quote- Filed May 12, 2026 · SEC Form D ↗
“Name of Issuer: Pagari Life Science Corp.; CIK: 1993125; Address: Bethalta, IL; Submission type: D; Filing date: 2026-05-12; Industry Group: Pharmaceuticals; Date of First Sale: 2026-04-28; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 300000; Total Amount Sold: 97494; Federal exemptions: 06b”
| Apr 28, 2026 | SEC Form D ↗ |
| Perimeter Medical Imaging AI | SEC Form D Debt / note · Form D reports $4M soldSource quote- Filed Jun 3, 2026 · amended Jun 18, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: Perimeter Medical Imaging AI, Inc.; CIK: 1818286; Address: Ontario, Canada; Submission type: D/A; Filing date: 2026-06-18; Industry Group: Other Health Care; Date of First Sale: 2026-04-27; Types of Securities Offered: Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 4000000; Total Amount Sold: 4000000; Federal exemptions: 06b”
| Apr 27, 2026 | SEC Form D/A ↗ |
| Cresilon | SEC Form D Debt / note · Form D reports $29M soldSource quote- Filed Apr 29, 2026 · amended Jun 26, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: Cresilon, Inc.; CIK: 1728054; Address: Brooklyn, NY; Submission type: D/A; Filing date: 2026-06-26; Industry Group: Biotechnology; Date of First Sale: 2026-04-24; Types of Securities Offered: Debt, Option/warrant; Business combination transaction: false; Total Offering Amount: 29000000; Total Amount Sold: 28999199; Federal exemptions: 06c”
| Apr 24, 2026 | SEC Form D/A ↗ |
| Scitara | SEC Form D Debt / note · Form D reports $5M soldSource quote- Filed Jun 18, 2026 · SEC Form D ↗
“Name of Issuer: Scitara Corp; CIK: 1788003; Address: Marlborough, MA; Submission type: D; Filing date: 2026-06-18; Industry Group: Other Technology; Date of First Sale: 2026-04-24; Types of Securities Offered: Debt, Other (Convertible Promissory Notes); Business combination transaction: false; Total Offering Amount: 5000000; Total Amount Sold: 5000000; Federal exemptions: 06b”
| Apr 24, 2026 | SEC Form D ↗ |
| Natsar Pharmaceuticals, Inc. | SEC Form D Equity · Form D reports $4.22M sold (offering size open-ended)Source quote- Filed May 8, 2026 · SEC Form D ↗
“Name of Issuer: Natsar Pharmaceuticals, Inc.; CIK: 2134002; Address: Ellicott City, MD; Submission type: D; Filing date: 2026-05-08; Industry Group: Pharmaceuticals; Date of First Sale: 2026-04-23; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 4221000; Federal exemptions: 06b”
| Apr 23, 2026 | SEC Form D ↗ |
| Lighthouse Pharmaceuticals | SEC Form D Equity · Form D reports $15.21M soldSource quote- Filed May 7, 2026 · SEC Form D ↗
“Name of Issuer: Lighthouse Pharmaceuticals, Inc.; CIK: 2133359; Address: Novato, CA; Submission type: D; Filing date: 2026-05-07; Industry Group: Other; Date of First Sale: 2026-04-22; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 15206800; Total Amount Sold: 15206800; Federal exemptions: 06b”
| Apr 22, 2026 | SEC Form D ↗ |
| Verismo Therapeutics | SEC Form D Equity · Form D reports $28M soldSource quote- Filed May 20, 2026 · SEC Form D ↗
“Name of Issuer: Verismo Therapeutics, Inc.; CIK: 1855431; Address: Philadelphia, PA; Submission type: D; Filing date: 2026-05-20; Industry Group: Other Health Care; Date of First Sale: 2026-04-21; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 28000000; Total Amount Sold: 28000000; Federal exemptions: 06b”
| Apr 21, 2026 | SEC Form D ↗ |
| Mitera Biosciences | SEC Form D SAFE · Form D reports $1.1M sold of $3M offeredSource quote- Filed May 6, 2026 · SEC Form D ↗
“Name of Issuer: Mitera Biosciences Inc.; CIK: 2022224; Address: Bellevue, WA; Submission type: D; Filing date: 2026-05-06; Industry Group: Biotechnology; Date of First Sale: 2026-04-21; Types of Securities Offered: Option/warrant, Security to be acquired, Other (Simple Agreement for Future Equity); Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 1100000; Federal exemptions: 06b”
| Apr 21, 2026 | SEC Form D ↗ |
| Enveric Biosciences | SEC Form D Equity · Form D reports $5M soldSource quote- Filed May 4, 2026 · SEC Form D ↗
“Name of Issuer: Enveric Biosciences, Inc.; CIK: 890821; Address: Cambridge, MA; Submission type: D; Filing date: 2026-05-04; Industry Group: Biotechnology; Date of First Sale: 2026-04-17; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 5000002; Total Amount Sold: 5000002; Federal exemptions: 06b”
| Apr 17, 2026 | SEC Form D ↗ |
| CASI Pharmaceuticals | SEC Form D Debt / note · Form D reports $5M soldSource quote- Filed Apr 28, 2026 · SEC Form D ↗
“Name of Issuer: CASI Pharmaceuticals, Inc.; CIK: 1962738; Address: Beijing, China; Submission type: D; Filing date: 2026-04-28; Industry Group: Pharmaceuticals; Date of First Sale: 2026-04-17; Types of Securities Offered: Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 5000000; Total Amount Sold: 5000000; Federal exemptions: 06b”
| Apr 17, 2026 | SEC Form D ↗ |
| Athos Therapeutics | SEC Form D Debt / note · Form D reports $10.28M sold of $20M offeredSource quote- Filed May 15, 2026 · SEC Form D ↗
“Name of Issuer: Athos Therapeutics, Inc.; CIK: 1885079; Address: Torrance, CA; Submission type: D; Filing date: 2026-05-15; Industry Group: Pharmaceuticals; Date of First Sale: 2026-04-17; Types of Securities Offered: Debt, Security to be acquired; Business combination transaction: false; Total Offering Amount: 20000000; Total Amount Sold: 10282887; Federal exemptions: 06b”
| Apr 17, 2026 | SEC Form D ↗ |
| Preceptis Medical | SEC Form D Equity · Form D reports $2.56M sold of $6.9M offeredSource quote- Filed May 1, 2026 · SEC Form D ↗
“Name of Issuer: Preceptis Medical, Inc.; CIK: 1537953; Address: Golden Valley, MN; Submission type: D; Filing date: 2026-05-01; Industry Group: Other Health Care; Date of First Sale: 2026-04-16; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 6900000; Total Amount Sold: 2561370; Federal exemptions: 06b”
| Apr 16, 2026 | SEC Form D ↗ |
| Illexcor Therapeutics | SEC Form D Equity · Form D reports $13M sold of $69M offeredSource quote- Filed May 8, 2026 · SEC Form D ↗
“Name of Issuer: Illexcor Therapeutics, Inc.; CIK: 2132799; Address: Henrico, VA; Submission type: D; Filing date: 2026-05-08; Industry Group: Biotechnology; Date of First Sale: 2026-04-15; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 69000000; Total Amount Sold: 13000000; Federal exemptions: 06b”
| Apr 15, 2026 | SEC Form D ↗ |
| General Oncology | SEC Form D SAFE · Form D reports $4.81M soldSource quote- Filed Apr 23, 2026 · SEC Form D ↗
“Name of Issuer: General Oncology, Inc.; CIK: 1658021; Address: Newton, MA; Submission type: D; Filing date: 2026-04-23; Industry Group: Pharmaceuticals; Date of First Sale: 2026-04-15; Types of Securities Offered: Option/warrant, Other (Simple Agreement for Future Equity (SAFE), the shares of Issuer capital stock into which the SAFE may convert (SAFE Shares), and the shares of Issuer capital stock into which the SAFE Shares may convert.); Business combination transaction: false; Total Offering Amount: 4805299; Total Amount Sold: 4805299; Federal exemptions: 06b”
| Apr 15, 2026 | SEC Form D ↗ |
| PanGIA Biotech | SEC Form D Debt / note · Form D reports $1.58M soldSource quote- Filed May 11, 2026 · SEC Form D ↗
“Name of Issuer: PANGIA BIOTECH, INC.; CIK: 2125789; Address: Delray Beach, FL; Submission type: D; Filing date: 2026-05-11; Industry Group: Biotechnology; Date of First Sale: 2026-04-08; Types of Securities Offered: Debt, Option/warrant; Business combination transaction: false; Total Offering Amount: 1580000; Total Amount Sold: 1580000; Federal exemptions: 06c”
| Apr 8, 2026 | SEC Form D ↗ |
| Tetrous | SEC Form D Equity · Form D reports $1.74M sold of $4M offeredSource quote- Filed Apr 22, 2026 · SEC Form D ↗
“Name of Issuer: Tetrous, Inc.; CIK: 2002357; Address: Sherman Oaks, CA; Submission type: D; Filing date: 2026-04-22; Industry Group: Biotechnology; Date of First Sale: 2026-04-08; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 4000000; Total Amount Sold: 1741024; Federal exemptions: 06b”
| Apr 8, 2026 | SEC Form D ↗ |
| Click Therapeutics, Inc. | SEC Form D Equity · Form D reports $50M soldSource quote- Filed Oct 1, 2026 · SEC Form D ↗
“Name of Issuer: Click Therapeutics, Inc.; CIK: 1623326; Address: New York, NY; Submission type: D; Filing date: 2026-10-01; Industry Group: Other Health Care; Date of First Sale: 2026-04-07; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 49999999; Total Amount Sold: 49999999; Federal exemptions: 06b”
| Apr 7, 2026 | SEC Form D ↗ |
| Bonum Therapeutics | SEC Form D Equity · Form D reports $26.91M sold of $32.3M offeredSource quote- Filed Apr 17, 2026 · SEC Form D ↗
“Name of Issuer: Bonum Therapeutics, Inc.; CIK: 1898714; Address: Seattle, WA; Submission type: D; Filing date: 2026-04-17; Industry Group: Biotechnology; Date of First Sale: 2026-04-03; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 32301381; Total Amount Sold: 26907396; Federal exemptions: 06b”
| Apr 3, 2026 | SEC Form D ↗ |
| Bond Biosciences | SEC Form D Equity · Form D reports $7.61M sold of $15M offeredSource quote- Filed Apr 8, 2026 · amended Oct 5, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: Bond Biosciences, Inc.; CIK: 1824224; Address: Parkville, MO; Submission type: D/A; Filing date: 2026-10-05; Industry Group: Other Health Care; Date of First Sale: 2026-04-01; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 15000000; Total Amount Sold: 7614879; Federal exemptions: 06b”
| Apr 1, 2026 | SEC Form D/A ↗ |
| Calyxo | SEC Form D Equity · Form D reports $40.1M soldSource quote- Filed Apr 16, 2026 · SEC Form D ↗
“Name of Issuer: Calyxo, Inc.; CIK: 1668653; Address: Pleasanton, CA; Submission type: D; Filing date: 2026-04-16; Industry Group: Other Health Care; Date of First Sale: 2026-04-01; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 40099963; Total Amount Sold: 40099963; Federal exemptions: 06b”
| Apr 1, 2026 | SEC Form D ↗ |
| EnteroBiotix | SEC Form D Equity · Form D reports $5.34M sold (offering size open-ended)Source quote- Filed Apr 9, 2026 · SEC Form D ↗
“Name of Issuer: EnteroBiotix LTD; CIK: 1946072; Address: Glasgow, United Kingdom; Submission type: D; Filing date: 2026-04-09; Industry Group: Biotechnology; Date of First Sale: 2026-03-30; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 5341593; Federal exemptions: 06b”
| Mar 30, 2026 | SEC Form D ↗ |
| Gilgamesh Pharma | SEC Form D SAFE · Form D reports $2.25M sold of $15M offeredSource quote- Filed Mar 31, 2026 · SEC Form D ↗
“Name of Issuer: Gilgamesh Pharma Inc.; CIK: 2107396; Address: New York, NY; Submission type: D; Filing date: 2026-03-31; Industry Group: Pharmaceuticals; Date of First Sale: 2026-03-27; Types of Securities Offered: Option/warrant, Other (Simple Agreement for Future Equity (SAFE), the shares of Issuer capital stock into which the SAFE may convert (SAFE Shares), and the shares of Issuer capital stock into which the SAFE Shares may convert.); Business combination transaction: false; Total Offering Amount: 15000000; Total Amount Sold: 2250000; Federal exemptions: 06b”
| Mar 27, 2026 | SEC Form D ↗ |
| Novel Microdevices | SEC Form D Debt / note · Form D reports $1M sold of $8M offeredSource quote- Filed Apr 27, 2026 · SEC Form D ↗
“Name of Issuer: Novel Microdevices, Inc.; CIK: 1837242; Address: Baltimore, MD; Submission type: D; Filing date: 2026-04-27; Industry Group: Other; Date of First Sale: 2026-03-27; Types of Securities Offered: Debt, Other (Convertible Promissory Note); Business combination transaction: false; Total Offering Amount: 8000000; Total Amount Sold: 1000000; Federal exemptions: 06b”
| Mar 27, 2026 | SEC Form D ↗ |
| TAS Medical | SEC Form D Equity · Form D reports $3.89M sold of $6.51M offeredSource quote- Filed Apr 10, 2026 · SEC Form D ↗
“Name of Issuer: TAS Medical, Inc.; CIK: 1739794; Address: Windermere, FL; Submission type: D; Filing date: 2026-04-10; Industry Group: Other Technology; Date of First Sale: 2026-03-27; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 6511056; Total Amount Sold: 3888800; Federal exemptions: 06b”
| Mar 27, 2026 | SEC Form D ↗ |
| Optimvia | SEC Form D Equity · Form D reports $75K sold of $500K offeredSource quote- Filed Apr 8, 2026 · SEC Form D ↗
“Name of Issuer: Optimvia, LLC; CIK: 1705874; Address: Cincinnati, OH; Submission type: D; Filing date: 2026-04-08; Industry Group: Other Health Care; Date of First Sale: 2026-03-26; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 500000; Total Amount Sold: 75000; Federal exemptions: 06b”
| Mar 26, 2026 | SEC Form D ↗ |
| Alume Biosciences, Inc. | SEC Form D SAFE · Form D reports $2.16M sold of $8M offeredSource quote- Filed Apr 6, 2026 · amended May 8, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: Alume Biosciences Inc; CIK: 1782348; Address: LA Jolla, CA; Submission type: D/A; Filing date: 2026-05-08; Industry Group: Biotechnology; Date of First Sale: 2026-03-24; Types of Securities Offered: Option/warrant, Security to be acquired, Other (Simple Agreement for Future Equity); Business combination transaction: false; Total Offering Amount: 8000000; Total Amount Sold: 2160000; Federal exemptions: 06b”
| Mar 24, 2026 | SEC Form D/A ↗ |
| Myra EB Systems | SEC Form D Debt / note · Form D reports $10K sold of $2M offeredSource quote- Filed Apr 7, 2026 · SEC Form D ↗
“Name of Issuer: Myra EB Systems LLC; CIK: 2125905; Address: Boxborough, MA; Submission type: D; Filing date: 2026-04-07; Industry Group: Biotechnology; Date of First Sale: 2026-03-24; Types of Securities Offered: Debt, Option/warrant; Business combination transaction: false; Total Offering Amount: 2000000; Total Amount Sold: 10000; Federal exemptions: 06b”
| Mar 24, 2026 | SEC Form D ↗ |
| Artelo Biosciences | SEC Form D Debt / note · Form D reports $315K soldSource quote- Filed Mar 27, 2026 · SEC Form D ↗
“Name of Issuer: ARTELO BIOSCIENCES, INC.; CIK: 1621221; Address: Solana Beach, CA; Submission type: D; Filing date: 2026-03-27; Industry Group: Biotechnology; Date of First Sale: 2026-03-20; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 315000; Total Amount Sold: 315000; Federal exemptions: 06b”
| Mar 20, 2026 | SEC Form D ↗ |
| Affinity Biosensors | SEC Form D SAFE · Form D reports $4.9M sold of $10M offeredSource quote- Filed Mar 23, 2026 · amended Oct 14, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: AFFINITY BIOSENSORS LLC; CIK: 1424288; Address: Santa Barbara, CA; Submission type: D/A; Filing date: 2026-10-14; Industry Group: Other; Date of First Sale: 2026-03-20; Types of Securities Offered: Equity, Other (SAFE); Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 4904771; Federal exemptions: 06b”
| Mar 20, 2026 | SEC Form D/A ↗ |
| Pearl Diagnostics, Inc. | SEC Form D Equity · Form D reports $11.15M soldSource quote- Filed Apr 21, 2026 · SEC Form D ↗
“Name of Issuer: Pearl Diagnostics, Inc.; CIK: 1922830; Address: Baltimore, MD; Submission type: D; Filing date: 2026-04-21; Industry Group: Biotechnology; Date of First Sale: 2026-03-19; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 11150000; Total Amount Sold: 11150000; Federal exemptions: 06b”
| Mar 19, 2026 | SEC Form D ↗ |
| SurgiBox | SEC Form D SAFE · Form D reports $486K sold of $3M offeredSource quote- Filed Sep 17, 2026 · SEC Form D ↗
“Name of Issuer: SurgiBox Inc.; CIK: 1930227; Address: Cambridge, MA; Submission type: D; Filing date: 2026-09-17; Industry Group: Biotechnology; Date of First Sale: 2026-03-19; Types of Securities Offered: Security to be acquired, Other (Simple Agreement for Future Equity); Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 486000; Federal exemptions: 06b”
| Mar 19, 2026 | SEC Form D ↗ |
| Waypoint Orthopedics | SEC Form D Debt / note · Form D reports $300K soldSource quote- Filed Mar 19, 2026 · SEC Form D ↗
“Name of Issuer: Waypoint Orthopedics, Inc.; CIK: 1828399; Address: Malvern, PA; Submission type: D; Filing date: 2026-03-19; Industry Group: Other Health Care; Date of First Sale: 2026-03-16; Types of Securities Offered: Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 300000; Total Amount Sold: 300000; Federal exemptions: 06b”
| Mar 16, 2026 | SEC Form D ↗ |
| Jana Care | SEC Form D Equity · Form D reports $1.39M sold of $6M offeredSource quote- Filed Mar 26, 2026 · SEC Form D ↗
“Name of Issuer: Jana Care, Inc.; CIK: 1696563; Address: Watertown, MA; Submission type: D; Filing date: 2026-03-26; Industry Group: Other Health Care; Date of First Sale: 2026-03-12; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 5999995; Total Amount Sold: 1390635; Federal exemptions: 06b”
| Mar 12, 2026 | SEC Form D ↗ |
| Apnimed | SEC Form D Equity · Form D reports $25M soldSource quote- Filed Mar 27, 2026 · SEC Form D ↗
“Name of Issuer: Apnimed, Inc.; CIK: 1745648; Address: Cambridge, MA; Submission type: D; Filing date: 2026-03-27; Industry Group: Pharmaceuticals; Date of First Sale: 2026-03-11; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 24999994; Total Amount Sold: 24999994; Federal exemptions: 06b”
| Mar 11, 2026 | SEC Form D ↗ |
| Numerion Labs | SEC Form D Equity · Form D reports $19.79M sold of $35M offeredSource quote- Filed Mar 19, 2026 · SEC Form D ↗
“Name of Issuer: Numerion Labs, Inc.; CIK: 1736153; Address: San Francisco, CA; Submission type: D; Filing date: 2026-03-19; Industry Group: Biotechnology; Date of First Sale: 2026-03-10; Types of Securities Offered: Equity, Other (Offer and sale of Series D Preferred Stock and Common Stock issuable upon conversion thereof. Certain outstanding shares of Common Stock were exchanged for shares of a specific series of Issuer's Preferred Stock for no consideration.); Business combination transaction: false; Total Offering Amount: 35000000; Total Amount Sold: 19794945; Federal exemptions: 06b”
| Mar 10, 2026 | SEC Form D ↗ |
| Biosolution Designs | SEC Form D Equity · Form D reports $705K sold of $1.5M offeredSource quote- Filed Mar 12, 2026 · SEC Form D ↗
“Name of Issuer: BioSolution Designs, Inc.; CIK: 2110022; Address: Frederick, MD; Submission type: D; Filing date: 2026-03-12; Industry Group: Biotechnology; Date of First Sale: 2026-03-09; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 1500000; Total Amount Sold: 705000; Federal exemptions: 06b”
| Mar 9, 2026 | SEC Form D ↗ |
| Liquet Medical | SEC Form D Debt / note · Form D reports $75K sold of $1.5M offeredSource quote- Filed Mar 23, 2026 · SEC Form D ↗
“Name of Issuer: Liquet Medical Inc.; CIK: 1887812; Address: Glen Allen, VA; Submission type: D; Filing date: 2026-03-23; Industry Group: Other Health Care; Date of First Sale: 2026-03-07; Types of Securities Offered: Debt, Security to be acquired; Business combination transaction: false; Total Offering Amount: 1500000; Total Amount Sold: 75000; Federal exemptions: 06b”
| Mar 7, 2026 | SEC Form D ↗ |
| Consano Bio, Inc. | SEC Form D Equity · Form D reports $34.82M sold of $48.86M offeredSource quote- Filed Mar 20, 2026 · SEC Form D ↗
“Name of Issuer: Consano Bio, Inc.; CIK: 1981285; Address: Burlington, MA; Submission type: D; Filing date: 2026-03-20; Industry Group: Biotechnology; Date of First Sale: 2026-03-06; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 48858795; Total Amount Sold: 34824466; Federal exemptions: 06b”
| Mar 6, 2026 | SEC Form D ↗ |
| BioLattice Ophthalmics, Inc. Filed as BioLattice Ophthalmics, Inc, | SEC Form D Equity · Form D reports $575K sold of $2.5M offeredSource quote- Filed Mar 30, 2026 · SEC Form D ↗
“Name of Issuer: BioLattice Ophthalmics, Inc,; CIK: 2125596; Address: Philadelphia, PA; Submission type: D; Filing date: 2026-03-30; Industry Group: Biotechnology; Date of First Sale: 2026-03-06; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 2500000; Total Amount Sold: 575000; Federal exemptions: 06b”
| Mar 6, 2026 | SEC Form D ↗ |
| Marrow Access Technologies | SEC Form D Equity + debt/notes · Form D reports $100K sold of $300K offeredSource quote- Filed Apr 9, 2026 · SEC Form D ↗
“Name of Issuer: Marrow Access Technologies, Inc.; CIK: 1758381; Address: Eden Prairie, MN; Submission type: D; Filing date: 2026-04-09; Industry Group: Other Health Care; Date of First Sale: 2026-03-04; Types of Securities Offered: Equity, Debt; Business combination transaction: false; Total Offering Amount: 300000; Total Amount Sold: 100000; Federal exemptions: 06b”
| Mar 4, 2026 | SEC Form D ↗ |
| Kala Pharmaceuticals, Inc. Filed as KALA BIO, Inc. | SEC Form D Equity · Form D reports $1.75M soldSource quote- Filed Mar 17, 2026 · SEC Form D ↗
“Name of Issuer: KALA BIO, Inc.; CIK: 1479419; Address: Arlington, MA; Submission type: D; Filing date: 2026-03-17; Industry Group: Pharmaceuticals; Date of First Sale: 2026-03-03; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 1753500; Total Amount Sold: 1753500; Federal exemptions: 06b”
| Mar 3, 2026 | SEC Form D ↗ |
| Inso Biosciences Inc. | SEC Form D Debt / note · Form D reports $750K sold of $3M offeredSource quote- Filed Apr 10, 2026 · SEC Form D ↗
“Name of Issuer: Inso Biosciences Inc.; CIK: 1906426; Address: Ithaca, NY; Submission type: D; Filing date: 2026-04-10; Industry Group: Biotechnology; Date of First Sale: 2026-03-03; Types of Securities Offered: Debt, Option/warrant, Security to be acquired, Other (Convertible promissory notes convertible into equity securities of the Issuer and the equity securities to be acquired upon such conversion.); Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 750000; Federal exemptions: 06b”
| Mar 3, 2026 | SEC Form D ↗ |
| Inflammasome Therapeutics | SEC Form D Equity · Form D reports $13.16M soldSource quote- Filed May 4, 2026 · SEC Form D ↗
“Name of Issuer: Inflammasome Therapeutics, Inc.; CIK: 1989925; Address: Newton, MA; Submission type: D; Filing date: 2026-05-04; Industry Group: Biotechnology; Date of First Sale: 2026-02-27; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 13155645; Total Amount Sold: 13155645; Federal exemptions: 06b”
| Feb 27, 2026 | SEC Form D ↗ |
| Thrombolex | SEC Form D Equity + debt/notes · Form D reports $32.77M sold of $51.1M offeredSource quote- Filed Mar 12, 2026 · SEC Form D ↗
“Name of Issuer: Thrombolex, Inc.; CIK: 1703764; Address: Kingston, NJ; Submission type: D; Filing date: 2026-03-12; Industry Group: Other Health Care; Date of First Sale: 2026-02-26; Types of Securities Offered: Equity, Other (Includes Conversion of Outstanding Notes); Business combination transaction: false; Total Offering Amount: 51105000; Total Amount Sold: 32775000; Federal exemptions: 06b”
| Feb 26, 2026 | SEC Form D ↗ |
| Ramona Optics Inc. | SEC Form D Equity · Form D reports $26.04M sold of $31.04M offeredSource quote- Filed Mar 12, 2026 · SEC Form D ↗
“Name of Issuer: Ramona Optics, Inc.; CIK: 1841317; Address: Durham, NC; Submission type: D; Filing date: 2026-03-12; Industry Group: Biotechnology; Date of First Sale: 2026-02-25; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 31037360; Total Amount Sold: 26037360; Federal exemptions: 06b”
| Feb 25, 2026 | SEC Form D ↗ |
| GeneCapture | SEC Form D Debt / note · Form D reports $50K sold of $3M offeredSource quote- Filed Feb 26, 2026 · SEC Form D ↗
“Name of Issuer: GeneCapture, Inc.; CIK: 1559176; Address: Huntsville, AL; Submission type: D; Filing date: 2026-02-26; Industry Group: Other; Date of First Sale: 2026-02-25; Types of Securities Offered: Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 50000; Federal exemptions: 06b”
| Feb 25, 2026 | SEC Form D ↗ |
| Levita Magnetics Filed as Levita Magnetics International Corp. | SEC Form D Equity · Form D reports $30.71M sold of $57.71M offeredSource quote- Filed Apr 28, 2026 · SEC Form D ↗
“Name of Issuer: Levita Magnetics International Corp.; CIK: 1911389; Address: Mountain View, CA; Submission type: D; Filing date: 2026-04-28; Industry Group: Other Health Care; Date of First Sale: 2026-02-24; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 57707603; Total Amount Sold: 30707603; Federal exemptions: 06b”
| Feb 24, 2026 | SEC Form D ↗ |
| Alphina Therapeutics | SEC Form D SAFE · Form D reports $154K sold of $10M offeredSource quote- Filed Mar 16, 2026 · SEC Form D ↗
“Name of Issuer: Alphina Therapeutics, Inc.; CIK: 1882991; Address: New Haven, CT; Submission type: D; Filing date: 2026-03-16; Industry Group: Biotechnology; Date of First Sale: 2026-02-23; Types of Securities Offered: Option/warrant, Other (Simple Agreements for Future Equity (SAFEs)); Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 153715; Federal exemptions: 06b”
| Feb 23, 2026 | SEC Form D ↗ |
| Nuvaira | SEC Form D SAFE · Form D reports $35.76M sold of $63.58M offeredSource quote- Filed Mar 4, 2026 · SEC Form D ↗
“Name of Issuer: NUVAIRA, INC.; CIK: 1461990; Address: Minneapolis, MN; Submission type: D; Filing date: 2026-03-04; Industry Group: Other Health Care; Date of First Sale: 2026-02-20; Types of Securities Offered: Equity, Other (Conversion of SAFEs; Conversion of debt); Business combination transaction: false; Total Offering Amount: 63576279; Total Amount Sold: 35764878; Federal exemptions: 06b”
| Feb 20, 2026 | SEC Form D ↗ |
| Linnaeus Therapeutics | SEC Form D Equity · Form D reports $4.99M sold of $10M offeredSource quote- Filed Feb 27, 2026 · amended Apr 2, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: Linnaeus Therapeutics, Inc.; CIK: 1752026; Address: Haddonfield, NJ; Submission type: D/A; Filing date: 2026-04-02; Industry Group: Biotechnology; Date of First Sale: 2026-02-17; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 4992000; Federal exemptions: 06b”
| Feb 17, 2026 | SEC Form D/A ↗ |
| Slate Medicines | SEC Form D Equity · Form D reports $10M sold of $130M offeredSource quote- Filed Mar 11, 2026 · SEC Form D ↗
“Name of Issuer: Slate Medicines, Inc.; CIK: 2117806; Address: Boston, MA; Submission type: D; Filing date: 2026-03-11; Industry Group: Pharmaceuticals; Date of First Sale: 2026-02-17; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 130000000; Total Amount Sold: 9999992; Federal exemptions: 06b”
| Feb 17, 2026 | SEC Form D ↗ |
| Virtuoso Surgical | SEC Form D Equity · Form D reports $2.9M sold of $10M offeredSource quote- Filed May 11, 2026 · SEC Form D ↗
“Name of Issuer: Virtuoso Surgical, Inc.; CIK: 1742075; Address: Nashville, TN; Submission type: D; Filing date: 2026-05-11; Industry Group: Biotechnology; Date of First Sale: 2026-02-15; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 2900000; Federal exemptions: 06b”
| Feb 15, 2026 | SEC Form D ↗ |
| TetraScience | SEC Form D Equity · Form D reports $15M soldSource quote- Filed Feb 27, 2026 · SEC Form D ↗
“Name of Issuer: TetraScience, Inc.; CIK: 1855742; Address: Boston, MA; Submission type: D; Filing date: 2026-02-27; Industry Group: Other; Date of First Sale: 2026-02-13; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 14999985; Total Amount Sold: 14999985; Federal exemptions: 06b”
| Feb 13, 2026 | SEC Form D ↗ |
| Altesa BioSciences | SEC Form D Equity · Form D reports $75M soldSource quote- Filed Feb 23, 2026 · SEC Form D ↗
“Name of Issuer: Altesa BioSciences, Inc.; CIK: 1960618; Address: College Park, GA; Submission type: D; Filing date: 2026-02-23; Industry Group: Pharmaceuticals; Date of First Sale: 2026-02-13; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 74999986; Total Amount Sold: 74999986; Federal exemptions: 06b”
| Feb 13, 2026 | SEC Form D ↗ |
| Ancilia Biosciences | SEC Form D Equity · Form D reports $10.08M soldSource quote- Filed Apr 6, 2026 · SEC Form D ↗
“Name of Issuer: Ancilia Biosciences, Inc.; CIK: 1975776; Address: New York, NY; Submission type: D; Filing date: 2026-04-06; Industry Group: Other; Date of First Sale: 2026-02-13; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 10076464; Total Amount Sold: 10076464; Federal exemptions: 06b”
| Feb 13, 2026 | SEC Form D ↗ |
| Eldec Pharmaceuticals | SEC Form D Debt / note · Form D reports $200K sold of $1.5M offeredSource quote- Filed Feb 12, 2026 · SEC Form D ↗
“Name of Issuer: Eldec Pharmaceuticals, Inc.; CIK: 2110508; Address: Chapel Hill, NC; Submission type: D; Filing date: 2026-02-12; Industry Group: Pharmaceuticals; Date of First Sale: 2026-02-11; Types of Securities Offered: Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 1500000; Total Amount Sold: 200000; Federal exemptions: 06b”
| Feb 11, 2026 | SEC Form D ↗ |
| Aatru Medical | SEC Form D Debt / note · Form D reports $700K sold of $2M offeredSource quote- Filed Feb 18, 2026 · amended Aug 11, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: Aatru Medical LLC; CIK: 1709493; Address: Cleveland, OH; Submission type: D/A; Filing date: 2026-08-11; Industry Group: Other Health Care; Date of First Sale: 2026-02-10; Types of Securities Offered: Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 2000000; Total Amount Sold: 700000; Federal exemptions: 06b”
| Feb 10, 2026 | SEC Form D/A ↗ |
| ILIAD Biotechnologies | SEC Form D Equity · Form D reports $115.54M soldSource quote- Filed Feb 20, 2026 · SEC Form D ↗
“Name of Issuer: ILIAD BIOTECHNOLOGIES, INC.; CIK: 2112659; Address: Weston, FL; Submission type: D; Filing date: 2026-02-20; Industry Group: Biotechnology; Date of First Sale: 2026-02-05; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 115540057; Total Amount Sold: 115540057; Federal exemptions: 06b”
| Feb 5, 2026 | SEC Form D ↗ |
| Telesair | SEC Form D Equity · Form D reports $2.96M sold of $6M offeredSource quote- Filed Mar 18, 2026 · SEC Form D ↗
“Name of Issuer: Telesair, Inc.; CIK: 1964253; Address: Irvine, CA; Submission type: D; Filing date: 2026-03-18; Industry Group: Other Technology; Date of First Sale: 2026-02-04; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 6000000; Total Amount Sold: 2955791; Federal exemptions: 06b”
| Feb 4, 2026 | SEC Form D ↗ |
| PAVmed Inc. | SEC Form D Equity · Form D reports $30M sold of $60M offeredSource quote- Filed Feb 17, 2026 · SEC Form D ↗
“Name of Issuer: PAVmed Inc.; CIK: 1624326; Address: New York, NY; Submission type: D; Filing date: 2026-02-17; Industry Group: Other Health Care; Date of First Sale: 2026-02-03; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 60000000; Total Amount Sold: 30000000; Federal exemptions: 06b”
| Feb 3, 2026 | SEC Form D ↗ |
| Praeventix | SEC Form D Equity · Form D reports $5.6M soldSource quote- Filed Feb 13, 2026 · amended Sep 10, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: Praeventix, Inc.; CIK: 1952974; Address: Exton, PA; Submission type: D/A; Filing date: 2026-09-10; Industry Group: Biotechnology; Date of First Sale: 2026-02-03; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 5601950; Total Amount Sold: 5601950; Federal exemptions: 06b”
| Feb 3, 2026 | SEC Form D/A ↗ |
| Lexicon Pharmaceuticals | SEC Form D Equity · Form D reports $55.67M sold of $59.15M offeredSource quote- Filed Feb 17, 2026 · SEC Form D ↗
“Name of Issuer: LEXICON PHARMACEUTICALS, INC.; CIK: 1062822; Address: The Woodlands, TX; Submission type: D; Filing date: 2026-02-17; Industry Group: Pharmaceuticals; Date of First Sale: 2026-02-02; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 59150000; Total Amount Sold: 55668255; Federal exemptions: 06b”
| Feb 2, 2026 | SEC Form D ↗ |
| NexEos Diagnostics, Inc. | SEC Form D Equity · Form D reports $3M soldSource quote- Filed Feb 17, 2026 · SEC Form D ↗
“Name of Issuer: NexEos Diagnostics, Inc.; CIK: 1783828; Address: Chester Springs, PA; Submission type: D; Filing date: 2026-02-17; Industry Group: Other Health Care; Date of First Sale: 2026-02-02; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 3000000; Federal exemptions: 06b”
| Feb 2, 2026 | SEC Form D ↗ |
| Cognixion | SEC Form D Debt / note · Form D reports $4.05M soldSource quote- Filed Feb 3, 2026 · SEC Form D ↗
“Name of Issuer: Cognixion Corp; CIK: 1749036; Address: Santa Barbara, CA; Submission type: D; Filing date: 2026-02-03; Industry Group: Other; Date of First Sale: 2026-01-30; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 4050000; Total Amount Sold: 4050000; Federal exemptions: 06b”
| Jan 30, 2026 | SEC Form D ↗ |
| Trellis Bioscience | SEC Form D Equity · Form D reports $6.09M sold (offering size open-ended)Source quote- Filed May 15, 2026 · SEC Form D ↗
“Name of Issuer: Trellis Bioscience, Inc.; CIK: 1162015; Address: Redwood City, CA; Submission type: D; Filing date: 2026-05-15; Industry Group: Biotechnology; Date of First Sale: 2026-01-30; Types of Securities Offered: Equity, Other (Series C Interests); Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 6093000; Federal exemptions: 06b”
| Jan 30, 2026 | SEC Form D ↗ |
| Allinaire Therapeutics | SEC Form D Equity · Form D reports $700K soldSource quote- Filed Apr 14, 2026 · SEC Form D ↗
“Name of Issuer: Allinaire Therapeutics Inc.; CIK: 2113399; Address: Cleveland, OH; Submission type: D; Filing date: 2026-04-14; Industry Group: Other; Date of First Sale: 2026-01-30; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 700000; Total Amount Sold: 700000; Federal exemptions: 06b”
| Jan 30, 2026 | SEC Form D ↗ |
| GeniPhys | SEC Form D Equity · Form D reports $3M sold of $5.55M offeredSource quote- Filed Feb 13, 2026 · SEC Form D ↗
“Name of Issuer: GeniPhys, Inc.; CIK: 1955873; Address: Indianapolis, IN; Submission type: D; Filing date: 2026-02-13; Industry Group: Other Health Care; Date of First Sale: 2026-01-29; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 5550000; Total Amount Sold: 2999910; Federal exemptions: 06b”
| Jan 29, 2026 | SEC Form D ↗ |
| Mirum Pharmaceuticals | SEC Form D Equity · Form D reports $68.48M soldSource quote- Filed Jan 29, 2026 · SEC Form D ↗
“Name of Issuer: Mirum Pharmaceuticals, Inc.; CIK: 1759425; Address: Foster City, CA; Submission type: D; Filing date: 2026-01-29; Industry Group: Biotechnology; Date of First Sale: 2026-01-23; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 68480000; Total Amount Sold: 68480000; Federal exemptions: 06c”
| Jan 23, 2026 | SEC Form D ↗ |
| ImmunoMet Therapeutics | SEC Form D Equity · Form D reports $842K sold of $10M offeredSource quote- Filed Feb 5, 2026 · SEC Form D ↗
“Name of Issuer: Immunomet Therapeutics, Inc.; CIK: 2109829; Address: Houston, TX; Submission type: D; Filing date: 2026-02-05; Industry Group: Biotechnology; Date of First Sale: 2026-01-21; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 842211; Federal exemptions: 06b”
| Jan 21, 2026 | SEC Form D ↗ |
| Ruskid LLC | SEC Form D Equity · Form D reports $1.37M sold of $2M offeredSource quote- Filed Feb 13, 2026 · SEC Form D ↗
“Name of Issuer: RUSKID LLC; CIK: 2110722; Address: Rancho Santa FE, CA; Submission type: D; Filing date: 2026-02-13; Industry Group: Biotechnology; Date of First Sale: 2026-01-16; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 2000000; Total Amount Sold: 1370000; Federal exemptions: 06b”
| Jan 16, 2026 | SEC Form D ↗ |
| AirNexis Therapeutics | SEC Form D Equity · Form D reports $62M sold of $200M offeredSource quote- Filed Mar 9, 2026 · SEC Form D ↗
“Name of Issuer: AirNexis Therapeutics, Inc.; CIK: 2116194; Address: Palo Alto, CA; Submission type: D; Filing date: 2026-03-09; Industry Group: Biotechnology; Date of First Sale: 2026-01-09; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 200000000; Total Amount Sold: 62000000; Federal exemptions: 06b”
| Jan 9, 2026 | SEC Form D ↗ |
| MultiValent Biotherapies | SEC Form D Equity + debt/notes · Form D reports $10.01M sold (offering size open-ended)Source quote- Filed Mar 2, 2026 · SEC Form D ↗
“Name of Issuer: MultiValent Biotherapies, Inc.; CIK: 2107846; Address: Los Altos, CA; Submission type: D; Filing date: 2026-03-02; Industry Group: Biotechnology; Date of First Sale: 2026-01-09; Types of Securities Offered: Equity, Debt; Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 10012500; Federal exemptions: 06b”
| Jan 9, 2026 | SEC Form D ↗ |
| Spheryx, Inc. | SEC Form D Equity · Form D reports $500K sold of $2.7M offeredSource quote- Filed Jan 22, 2026 · SEC Form D ↗
“Name of Issuer: Spheryx, Inc.; CIK: 1630562; Address: New York, NY; Submission type: D; Filing date: 2026-01-22; Industry Group: Other; Date of First Sale: 2026-01-09; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 2700000; Total Amount Sold: 500400; Federal exemptions: 06b”
| Jan 9, 2026 | SEC Form D ↗ |
| TwoStep Therapeutics | SEC Form D Equity · Form D reports $21.11M sold of $62.21M offeredSource quote- Filed Jan 20, 2026 · SEC Form D ↗
“Name of Issuer: TwoStep Therapeutics, Inc.; CIK: 2015273; Address: San Carlos, CA; Submission type: D; Filing date: 2026-01-20; Industry Group: Other; Date of First Sale: 2026-01-09; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 62209510; Total Amount Sold: 21109518; Federal exemptions: 06b”
| Jan 9, 2026 | SEC Form D ↗ |
| Caldera Therapeutics | SEC Form D Equity · Form D reports $37.5M soldSource quote- Filed Jan 21, 2026 · SEC Form D ↗
“Name of Issuer: Caldera Therapeutics, Inc.; CIK: 2069936; Address: Cambridge, MA; Submission type: D; Filing date: 2026-01-21; Industry Group: Biotechnology; Date of First Sale: 2026-01-08; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 37500000; Total Amount Sold: 37500000; Federal exemptions: 06b”
| Jan 8, 2026 | SEC Form D ↗ |
| Entact Bio | SEC Form D Equity · Form D reports $10M soldSource quote- Filed Jun 3, 2026 · SEC Form D ↗
“Name of Issuer: Entact Bio, Inc.; CIK: 2008244; Address: Watertown, MA; Submission type: D; Filing date: 2026-06-03; Industry Group: Biotechnology; Date of First Sale: 2026-01-08; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 9999997; Total Amount Sold: 9999997; Federal exemptions: 06b”
| Jan 8, 2026 | SEC Form D ↗ |
| PrognomiQ | SEC Form D Equity · Form D reports $11.87M soldSource quote- Filed Jan 16, 2026 · SEC Form D ↗
“Name of Issuer: PrognomIQ, Inc.; CIK: 2034700; Address: San Mateo, CA; Submission type: D; Filing date: 2026-01-16; Industry Group: Other Health Care; Date of First Sale: 2026-01-02; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 11872784; Total Amount Sold: 11872784; Federal exemptions: 06b”
| Jan 2, 2026 | SEC Form D ↗ |
| Omega Ophthalmics | SEC Form D Equity · Form D reports $320K sold of $9.6M offeredSource quote- Filed Jan 15, 2026 · SEC Form D ↗
“Name of Issuer: Omega Ophthalmics LLC; CIK: 1937862; Address: Versailles, KY; Submission type: D; Filing date: 2026-01-15; Industry Group: Other; Date of First Sale: 2026-01-02; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 9600000; Total Amount Sold: 320000; Federal exemptions: 06b”
| Jan 2, 2026 | SEC Form D ↗ |
| Holobiome, Inc. | SEC Form D SAFE · Form D reports $10M soldSource quote- Filed Jul 22, 2026 · SEC Form D ↗
“Name of Issuer: Holobiome, Inc.; CIK: 1763027; Address: Boston, MA; Submission type: D; Filing date: 2026-07-22; Industry Group: Biotechnology; Date of First Sale: 2025-12-24; Types of Securities Offered: Other (Simple Agreement for Future Equity (SAFES)); Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 10000000; Federal exemptions: 06b”
| Dec 24, 2025 | SEC Form D ↗ |
| Phenomix Sciences | SEC Form D Equity · Form D reports $2.5M sold of $5M offeredSource quote- Filed Dec 29, 2025 · SEC Form D ↗
“Name of Issuer: Phenomix Sciences, Inc.; CIK: 1966746; Address: Menlo Park, CA; Submission type: D; Filing date: 2025-12-29; Industry Group: Other Health Care; Date of First Sale: 2025-12-23; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 5000004; Total Amount Sold: 2500002; Federal exemptions: 06b”
| Dec 23, 2025 | SEC Form D ↗ |
| Qureator | SEC Form D Equity · Form D reports $6.68M sold of $6.88M offeredSource quote- Filed Mar 6, 2026 · SEC Form D ↗
“Name of Issuer: Qureator, Inc.; CIK: 2109274; Address: San Diego, CA; Submission type: D; Filing date: 2026-03-06; Industry Group: Biotechnology; Date of First Sale: 2025-12-23; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 6881746; Total Amount Sold: 6680994; Federal exemptions: 06b”
| Dec 23, 2025 | SEC Form D ↗ |
| Cellanome | SEC Form D Equity · Form D reports $75.93M soldSource quote- Filed Jun 22, 2026 · SEC Form D ↗
“Name of Issuer: Cellanome, Inc.; CIK: 1886462; Address: Foster City, CA; Submission type: D; Filing date: 2026-06-22; Industry Group: Biotechnology; Date of First Sale: 2025-12-23; Types of Securities Offered: Equity, Other (Series C Preferred Stock); Business combination transaction: false; Total Offering Amount: 75930476; Total Amount Sold: 75930476; Federal exemptions: 06b”
| Dec 23, 2025 | SEC Form D ↗ |
| Adaptin Bio | SEC Form D Equity · Form D reports $1.91M sold of $4M offeredSource quote- Filed Jan 5, 2026 · amended Jun 22, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: ADAPTIN BIO, INC.; CIK: 1938571; Address: Charlotte, NC; Submission type: D/A; Filing date: 2026-06-22; Industry Group: Biotechnology; Date of First Sale: 2025-12-22; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 4000000; Total Amount Sold: 1912000; Federal exemptions: 06b”
| Dec 22, 2025 | SEC Form D/A ↗ |
| Slam BioTherapeutics | SEC Form D Debt / note · Form D reports $1M sold of $4M offeredSource quote- Filed Dec 29, 2025 · SEC Form D ↗
“Name of Issuer: SLAM BioTherapeutics, Inc.; CIK: 1983523; Address: Westlake Village, CA; Submission type: D; Filing date: 2025-12-29; Industry Group: Biotechnology; Date of First Sale: 2025-12-19; Types of Securities Offered: Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 4000000; Total Amount Sold: 1000000; Federal exemptions: 06b”
| Dec 19, 2025 | SEC Form D ↗ |
| Riverain Technologies | SEC Form D Equity · Form D reports $8.25M soldSource quote- Filed Jan 26, 2026 · SEC Form D ↗
“Name of Issuer: Riverain Technologies, Inc.; CIK: 2107191; Address: Miamisburg, OH; Submission type: D; Filing date: 2026-01-26; Industry Group: Other Health Care; Date of First Sale: 2025-12-19; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 8250000; Total Amount Sold: 8250000; Federal exemptions: 06b”
| Dec 19, 2025 | SEC Form D ↗ |
| RICOVR Healthcare Inc. | SEC Form D Equity · Form D reports $550K sold of $1.5M offeredSource quote- Filed Jan 20, 2026 · SEC Form D ↗
“Name of Issuer: Ricovr Healthcare Inc.; CIK: 1800521; Address: Princeton, NJ; Submission type: D; Filing date: 2026-01-20; Industry Group: Other Health Care; Date of First Sale: 2025-12-19; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 1500000; Total Amount Sold: 550000; Federal exemptions: 06b”
| Dec 19, 2025 | SEC Form D ↗ |
| Spiro Medical | SEC Form D Equity · Form D reports $37.1M sold of $69.1M offeredSource quote- Filed Jan 5, 2026 · SEC Form D ↗
“Name of Issuer: Spiro Medical Inc.; CIK: 1996433; Address: Belleair Bluffs, FL; Submission type: D; Filing date: 2026-01-05; Industry Group: Other Health Care; Date of First Sale: 2025-12-19; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 69095598; Total Amount Sold: 37095655; Federal exemptions: 06b”
| Dec 19, 2025 | SEC Form D ↗ |
| Axena Health | SEC Form D Equity + debt/notes · Form D reports $15.05M sold (offering size open-ended)Source quote- Filed Apr 14, 2026 · SEC Form D ↗
“Name of Issuer: Axena Health, Inc.; CIK: 1988865; Address: Auburndale, MA; Submission type: D; Filing date: 2026-04-14; Industry Group: Other Health Care; Date of First Sale: 2025-12-19; Types of Securities Offered: Equity, Option/warrant, Security to be acquired, Other (Convertibles); Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 15046942; Federal exemptions: 06b”
| Dec 19, 2025 | SEC Form D ↗ |
| Genialis | SEC Form D Debt / note · Form D reports $700K sold of $3M offeredSource quote- Filed Dec 31, 2025 · SEC Form D ↗
“Name of Issuer: Genialis, Inc.; CIK: 1948756; Address: Boston, MA; Submission type: D; Filing date: 2025-12-31; Industry Group: Biotechnology; Date of First Sale: 2025-12-17; Types of Securities Offered: Debt, Option/warrant; Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 700000; Federal exemptions: 06b”
| Dec 17, 2025 | SEC Form D ↗ |
| Healionics Corporation | SEC Form D Equity · Form D reports $1.96M sold of $20M offeredSource quote- Filed Dec 31, 2025 · SEC Form D ↗
“Name of Issuer: Healionics CORP; CIK: 1413969; Address: Seattle, WA; Submission type: D; Filing date: 2025-12-31; Industry Group: Other; Date of First Sale: 2025-12-16; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 20000000; Total Amount Sold: 1964221; Federal exemptions: 06b”
| Dec 16, 2025 | SEC Form D ↗ |
| DMC Biotechnologies, Inc. | SEC Form D Equity + debt/notes · Form D reports $1.41M sold of $2.5M offeredSource quote- Filed Dec 30, 2025 · SEC Form D ↗
“Name of Issuer: DMC Biotechnologies, Inc.; CIK: 1728411; Address: Boulder, CO; Submission type: D; Filing date: 2025-12-30; Industry Group: Biotechnology; Date of First Sale: 2025-12-16; Types of Securities Offered: Equity, Debt, Option/warrant, Security to be acquired, Other (Promissory notes convertible into equity securities of the Issuer and the equity securities to be issued upon such conversion); Business combination transaction: false; Total Offering Amount: 2500000; Total Amount Sold: 1414267; Federal exemptions: 06b”
| Dec 16, 2025 | SEC Form D ↗ |
| Nocion Therapeutics | SEC Form D Equity · Form D reports $23M soldSource quote- Filed Mar 13, 2026 · SEC Form D ↗
“Name of Issuer: Nocion Therapeutics, Inc.; CIK: 1841279; Address: Watertown, MA; Submission type: D; Filing date: 2026-03-13; Industry Group: Pharmaceuticals; Date of First Sale: 2025-12-15; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 22999999; Total Amount Sold: 22999999; Federal exemptions: 06b”
| Dec 15, 2025 | SEC Form D ↗ |
| Glycologix | SEC Form D Equity + debt/notes · Form D reports $800K sold of $1M offeredSource quote- Filed Dec 29, 2025 · SEC Form D ↗
“Name of Issuer: Glycologix, Inc.; CIK: 1903671; Address: Beverly, MA; Submission type: D; Filing date: 2025-12-29; Industry Group: Other Technology; Date of First Sale: 2025-12-12; Types of Securities Offered: Equity, Debt; Business combination transaction: false; Total Offering Amount: 1000000; Total Amount Sold: 800000; Federal exemptions: 06b”
| Dec 12, 2025 | SEC Form D ↗ |
| OXOS Medical | SEC Form D Equity · Form D reports $10.71M sold of $28.21M offeredSource quote- Filed Dec 19, 2025 · SEC Form D ↗
“Name of Issuer: OXOS MEDICAL, INC.; CIK: 1694304; Address: Atlanta, GA; Submission type: D; Filing date: 2025-12-19; Industry Group: Other Technology; Date of First Sale: 2025-12-12; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 28207000; Total Amount Sold: 10706990; Federal exemptions: 06b”
| Dec 12, 2025 | SEC Form D ↗ |
| Nacuity Pharmaceuticals | SEC Form D Equity + debt/notes · Form D reports $8.39M sold of $30M offeredSource quote- Filed Dec 30, 2025 · SEC Form D ↗
“Name of Issuer: Nacuity Pharmaceuticals, Inc.; CIK: 1690279; Address: Fort Worth, TX; Submission type: D; Filing date: 2025-12-30; Industry Group: Pharmaceuticals; Date of First Sale: 2025-12-11; Types of Securities Offered: Equity, Debt, Option/warrant, Security to be acquired, Other (Convertible Promissory Notes convertible into preferred stock or common stock, Common Stock Purchase Warrants, Common Stock issued for Warrant Conversion); Business combination transaction: false; Total Offering Amount: 30000000; Total Amount Sold: 8393350; Federal exemptions: 06b”
| Dec 11, 2025 | SEC Form D ↗ |
| Aprea Therapeutics | SEC Form D Equity · Form D reports $3.06M sold of $5.78M offeredSource quote- Filed Dec 29, 2025 · SEC Form D ↗
“Name of Issuer: Aprea Therapeutics, Inc.; CIK: 1781983; Address: Doylestown, PA; Submission type: D; Filing date: 2025-12-29; Industry Group: Biotechnology; Date of First Sale: 2025-12-10; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 5783766; Total Amount Sold: 3055822; Federal exemptions: 06b”
| Dec 10, 2025 | SEC Form D ↗ |
| Mediar Therapeutics | SEC Form D Equity · Form D reports $37.85M sold of $75.7M offeredSource quote- Filed Dec 23, 2025 · SEC Form D ↗
“Name of Issuer: Mediar Therapeutics, Inc.; CIK: 1766784; Address: Boston, MA; Submission type: D; Filing date: 2025-12-23; Industry Group: Biotechnology; Date of First Sale: 2025-12-10; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 75699630; Total Amount Sold: 37849815; Federal exemptions: 06b”
| Dec 10, 2025 | SEC Form D ↗ |
| Vogenx | SEC Form D Debt / note · Form D reports $750K sold of $5M offeredSource quote- Filed Jan 7, 2026 · SEC Form D ↗
“Name of Issuer: Vogenx, Inc.; CIK: 1903784; Address: Raleigh, NC; Submission type: D; Filing date: 2026-01-07; Industry Group: Pharmaceuticals; Date of First Sale: 2025-12-10; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 5000000; Total Amount Sold: 750000; Federal exemptions: 06b”
| Dec 10, 2025 | SEC Form D ↗ |
| Aethlon Medical, Inc. | SEC Form D Equity · Form D reports $2.15M soldSource quote- Filed Dec 23, 2025 · SEC Form D ↗
“Name of Issuer: AETHLON MEDICAL INC; CIK: 882291; Address: San Diego, CA; Submission type: D; Filing date: 2025-12-23; Industry Group: Biotechnology; Date of First Sale: 2025-12-08; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 2153700; Total Amount Sold: 2153700; Federal exemptions: 06b”
| Dec 8, 2025 | SEC Form D ↗ |
| Innovaprep LLC | SEC Form D Debt / note · Form D reports $100K sold of $1M offeredSource quote- Filed Dec 17, 2025 · SEC Form D ↗
“Name of Issuer: INNOVAPREP INC.; CIK: 1753878; Address: Drexel, MO; Submission type: D; Filing date: 2025-12-17; Industry Group: Biotechnology; Date of First Sale: 2025-12-05; Types of Securities Offered: Debt, Option/warrant; Business combination transaction: false; Total Offering Amount: 1000000; Total Amount Sold: 100000; Federal exemptions: 06b”
| Dec 5, 2025 | SEC Form D ↗ |
| OrthoPreserve | SEC Form D Debt / note · Form D reports $157K sold of $2M offeredSource quote- Filed Dec 23, 2025 · SEC Form D ↗
“Name of Issuer: OrthoPreserve, Inc.; CIK: 2034639; Address: Henrico, VA; Submission type: D; Filing date: 2025-12-23; Industry Group: Other Health Care; Date of First Sale: 2025-12-04; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 2000000; Total Amount Sold: 157000; Federal exemptions: 06b”
| Dec 4, 2025 | SEC Form D ↗ |
| Amphix Bio, Inc. | SEC Form D Equity · Form D reports $10.3M sold of $12.5M offeredSource quote- Filed Dec 19, 2025 · SEC Form D ↗
“Name of Issuer: Amphix Bio, Inc.; CIK: 2101704; Address: Chicago, IL; Submission type: D; Filing date: 2025-12-19; Industry Group: Biotechnology; Date of First Sale: 2025-12-04; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 12500000; Total Amount Sold: 10300000; Federal exemptions: 06b”
| Dec 4, 2025 | SEC Form D ↗ |
| Oncotelic Therapeutics | SEC Form D Equity + debt/notes · Form D reports $275K sold of $12.5M offeredSource quote- Filed Dec 11, 2025 · SEC Form D ↗
“Name of Issuer: Oncotelic Therapeutics, Inc.; CIK: 908259; Address: Agoura Hills, CA; Submission type: D; Filing date: 2025-12-11; Industry Group: Biotechnology; Date of First Sale: 2025-12-04; Types of Securities Offered: Equity, Debt, Security to be acquired; Business combination transaction: false; Total Offering Amount: 12500000; Total Amount Sold: 275000; Federal exemptions: 06b”
| Dec 4, 2025 | SEC Form D ↗ |
| Kazia Therapeutics Limited Filed as KAZIA THERAPEUTICS LTD | SEC Form D Equity · Form D reports $55.25M soldSource quote- Filed Dec 18, 2025 · SEC Form D ↗
“Name of Issuer: KAZIA THERAPEUTICS LTD; CIK: 1075880; Address: Sydney Nsw, Australia; Submission type: D; Filing date: 2025-12-18; Industry Group: Biotechnology; Date of First Sale: 2025-12-03; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 55251088; Total Amount Sold: 55251088; Federal exemptions: 06b”
| Dec 3, 2025 | SEC Form D ↗ |
| DELFI Diagnostics | SEC Form D Debt / note · Form D reports $34.33M sold of $60M offeredSource quote- Filed Dec 18, 2025 · SEC Form D ↗
“Name of Issuer: Delfi Diagnostics, Inc.; CIK: 1783735; Address: Palo Alto, CA; Submission type: D; Filing date: 2025-12-18; Industry Group: Biotechnology; Date of First Sale: 2025-12-01; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 60000000; Total Amount Sold: 34333315; Federal exemptions: 06b”
| Dec 1, 2025 | SEC Form D ↗ |
| Novilytic | SEC Form D Equity · Form D reports $531K sold of $1M offeredSource quote- Filed Dec 15, 2025 · SEC Form D ↗
“Name of Issuer: Novilytic, LLC; CIK: 1850261; Address: West Lafayette, IN; Submission type: D; Filing date: 2025-12-15; Industry Group: Biotechnology; Date of First Sale: 2025-12-01; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 1000000; Total Amount Sold: 530800; Federal exemptions: 06b”
| Dec 1, 2025 | SEC Form D ↗ |
| Telos Biotech | SEC Form D Equity · Form D reports $725K sold of $2.25M offeredSource quote- Filed Dec 12, 2025 · SEC Form D ↗
“Name of Issuer: Telos Biotech Inc.; CIK: 1815708; Address: Dallas, TX; Submission type: D; Filing date: 2025-12-12; Industry Group: Biotechnology; Date of First Sale: 2025-12-01; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 2250000; Total Amount Sold: 724999; Federal exemptions: 06b”
| Dec 1, 2025 | SEC Form D ↗ |
| Minnesota Medical Technologies | SEC Form D Equity · Form D reports $8.28M sold of $17M offeredSource quote- Filed Dec 10, 2025 · SEC Form D ↗
“Name of Issuer: Minnesota Medical Technologies Corp; CIK: 1736524; Address: Stewartville, MN; Submission type: D; Filing date: 2025-12-10; Industry Group: Other Health Care; Date of First Sale: 2025-12-01; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 16999964; Total Amount Sold: 8279547; Federal exemptions: 06b”
| Dec 1, 2025 | SEC Form D ↗ |
| Zeo Scientifix | SEC Form D Equity · Form D reports $500K sold of $5M offeredSource quote- Filed Dec 5, 2025 · SEC Form D ↗
“Name of Issuer: Zeo ScientifiX, Inc.; CIK: 1557376; Address: Davie, FL; Submission type: D; Filing date: 2025-12-05; Industry Group: Biotechnology; Date of First Sale: 2025-11-30; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 5000000; Total Amount Sold: 500000; Federal exemptions: 06b”
| Nov 30, 2025 | SEC Form D ↗ |
| TRIANA Biomedicines, Inc. | SEC Form D Equity · Form D reports $120.06M soldSource quote- Filed Dec 4, 2025 · SEC Form D ↗
“Name of Issuer: Triana Biomedicines, Inc.; CIK: 1815337; Address: Lexington, MA; Submission type: D; Filing date: 2025-12-04; Industry Group: Pharmaceuticals; Date of First Sale: 2025-11-26; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 120061960; Total Amount Sold: 120061960; Federal exemptions: 06b”
| Nov 26, 2025 | SEC Form D ↗ |
| Life Biosciences Inc. | SEC Form D Equity · Form D reports $31M soldSource quote- Filed Apr 24, 2026 · SEC Form D ↗
“Name of Issuer: Life Biosciences LLC; CIK: 1751806; Address: Boston, MA; Submission type: D; Filing date: 2026-04-24; Industry Group: Other; Date of First Sale: 2025-11-25; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 31000002; Total Amount Sold: 31000002; Federal exemptions: 06b”
| Nov 25, 2025 | SEC Form D ↗ |
| Prana Therapies, Inc. | SEC Form D Equity · Form D reports $40.23M soldSource quote- Filed Aug 10, 2026 · SEC Form D ↗
“Name of Issuer: Prana Therapies, Inc.; CIK: 2029240; Address: Encinitas, CA; Submission type: D; Filing date: 2026-08-10; Industry Group: Biotechnology; Date of First Sale: 2025-11-25; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 40226932; Total Amount Sold: 40226932; Federal exemptions: 06b”
| Nov 25, 2025 | SEC Form D ↗ |
| MindImmune Therapeutics | SEC Form D Equity · Form D reports $15.22M sold of $17.01M offeredSource quote- Filed Dec 5, 2025 · amended Mar 5, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: MindImmune Therapeutics, Inc.; CIK: 1792522; Address: Kingston, RI; Submission type: D/A; Filing date: 2026-03-05; Industry Group: Pharmaceuticals; Date of First Sale: 2025-11-24; Types of Securities Offered: Equity, Security to be acquired; Business combination transaction: false; Total Offering Amount: 17014485; Total Amount Sold: 15218343; Federal exemptions: 06b”
| Nov 24, 2025 | SEC Form D/A ↗ |
| NextStep Robotics Inc. | SEC Form D SAFE · Form D reports $1M sold of $3M offeredSource quote- Filed Apr 9, 2026 · SEC Form D ↗
“Name of Issuer: NEXTSTEP ROBOTICS, INC.; CIK: 1729819; Address: Baltimore, MD; Submission type: D; Filing date: 2026-04-09; Industry Group: Other Technology; Date of First Sale: 2025-11-24; Types of Securities Offered: Option/warrant, Security to be acquired, Other (SIMPLE AGREEMENT FOR FUTURE EQUITY); Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 1000000; Federal exemptions: 06b”
| Nov 24, 2025 | SEC Form D ↗ |
| Paulex Bio | SEC Form D Equity · Form D reports $18.52M sold of $22.5M offeredSource quote- Filed Dec 18, 2025 · SEC Form D ↗
“Name of Issuer: Paulex Bio Inc.; CIK: 2071082; Address: LA Jolla, CA; Submission type: D; Filing date: 2025-12-18; Industry Group: Pharmaceuticals; Date of First Sale: 2025-11-21; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 22500000; Total Amount Sold: 18516040; Federal exemptions: 06c”
| Nov 21, 2025 | SEC Form D ↗ |
| Relation Therapeutics | SEC Form D Debt / note · Form D reports $36.17M soldSource quote- Filed Dec 9, 2025 · SEC Form D ↗
“Name of Issuer: Relation Therapeutics Inc.; CIK: 1876828; Address: Miami Beach, FL; Submission type: D; Filing date: 2025-12-09; Industry Group: Biotechnology; Date of First Sale: 2025-11-21; Types of Securities Offered: Debt, Security to be acquired, Other (Convertible Promissory Note); Business combination transaction: false; Total Offering Amount: 36175000; Total Amount Sold: 36175000; Federal exemptions: 06b”
| Nov 21, 2025 | SEC Form D ↗ |
| A-Synaptic Pharma Filed as A-SYNAPTIC CORP. | SEC Form D Equity · Form D reports $533K sold of $2M offeredSource quote- Filed Dec 4, 2025 · SEC Form D ↗
“Name of Issuer: A-SYNAPTIC CORP.; CIK: 1913553; Address: Ontario, Canada; Submission type: D; Filing date: 2025-12-04; Industry Group: Other; Date of First Sale: 2025-11-21; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 2000000; Total Amount Sold: 533100; Federal exemptions: 06b”
| Nov 21, 2025 | SEC Form D ↗ |
| Armonica Technologies, Inc. | SEC Form D Equity · Form D reports $4.21M sold of $5.71M offeredSource quote- Filed Dec 8, 2025 · SEC Form D ↗
“Name of Issuer: Armonica Technologies, Inc.; CIK: 1714729; Address: Albuquerque, NM; Submission type: D; Filing date: 2025-12-08; Industry Group: Biotechnology; Date of First Sale: 2025-11-20; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 5714702; Total Amount Sold: 4214700; Federal exemptions: 06b”
| Nov 20, 2025 | SEC Form D ↗ |
| Nature's Toolbox | SEC Form D Equity · Form D reports $10.37M sold of $15M offeredSource quote- Filed Dec 23, 2025 · amended Feb 4, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: Nature's Toolbox, Inc.; CIK: 1798793; Address: Rio Rancho, NM; Submission type: D/A; Filing date: 2026-02-04; Industry Group: Biotechnology; Date of First Sale: 2025-11-19; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 15001975; Total Amount Sold: 10365162; Federal exemptions: 06b”
| Nov 19, 2025 | SEC Form D/A ↗ |
| Aeovian Pharmaceuticals | SEC Form D Equity · Form D reports $55M soldSource quote- Filed Dec 22, 2025 · SEC Form D ↗
“Name of Issuer: Aeovian Pharmaceuticals, Inc.; CIK: 1710088; Address: Berkeley, CA; Submission type: D; Filing date: 2025-12-22; Industry Group: Pharmaceuticals; Date of First Sale: 2025-11-18; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 54999996; Total Amount Sold: 54999996; Federal exemptions: 06b”
| Nov 18, 2025 | SEC Form D ↗ |
| Okami Medical | SEC Form D Equity · Form D reports $28.94M sold of $46.73M offeredSource quote- Filed Dec 1, 2025 · SEC Form D ↗
“Name of Issuer: Okami Medical, Inc.; CIK: 1675564; Address: Aliso Viejo, CA; Submission type: D; Filing date: 2025-12-01; Industry Group: Other Technology; Date of First Sale: 2025-11-18; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 46735000; Total Amount Sold: 28936718; Federal exemptions: 06b”
| Nov 18, 2025 | SEC Form D ↗ |
| BTB Therapeutics | SEC Form D Equity · Form D reports $8.9M sold of $10.4M offeredSource quote- Filed Dec 1, 2025 · amended Aug 12, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: BTB Therapeutics, Inc.; CIK: 2055053; Address: Escondido, CA; Submission type: D/A; Filing date: 2026-08-12; Industry Group: Pharmaceuticals; Date of First Sale: 2025-11-14; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 10402704; Total Amount Sold: 8902204; Federal exemptions: 06b”
| Nov 14, 2025 | SEC Form D/A ↗ |
| Allurion Technologies | SEC Form D Equity · Form D reports $5M soldSource quote- Filed Nov 26, 2025 · SEC Form D ↗
“Name of Issuer: ALLURION TECHNOLOGIES, INC.; CIK: 1964979; Address: Natick, MA; Submission type: D; Filing date: 2025-11-26; Industry Group: Other Health Care; Date of First Sale: 2025-11-14; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 5000000; Total Amount Sold: 5000000; Federal exemptions: 06b”
| Nov 14, 2025 | SEC Form D ↗ |
| Ablative Solutions | SEC Form D Equity · Form D reports $10.41M sold of $45M offeredSource quote- Filed Nov 26, 2025 · SEC Form D ↗
“Name of Issuer: Ablative Solutions, Inc.; CIK: 1535723; Address: Wakefield, MA; Submission type: D; Filing date: 2025-11-26; Industry Group: Other Health Care; Date of First Sale: 2025-11-14; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 45000000; Total Amount Sold: 10407500; Federal exemptions: 06b”
| Nov 14, 2025 | SEC Form D ↗ |
| Repair Biotechnologies | SEC Form D Equity · Form D reports $5.26M sold of $11M offeredSource quote- Filed Nov 25, 2025 · SEC Form D ↗
“Name of Issuer: Repair Biotechnologies, Inc.; CIK: 1750699; Address: Syracuse, NY; Submission type: D; Filing date: 2025-11-25; Industry Group: Biotechnology; Date of First Sale: 2025-11-14; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 11000000; Total Amount Sold: 5258906; Federal exemptions: 06b”
| Nov 14, 2025 | SEC Form D ↗ |
| Solve Therapeutics | SEC Form D Equity · Form D reports $48.21M sold of $120.54M offeredSource quote- Filed Nov 25, 2025 · SEC Form D ↗
“Name of Issuer: Solve Therapeutics, Inc.; CIK: 1905252; Address: Belmont, CA; Submission type: D; Filing date: 2025-11-25; Industry Group: Biotechnology; Date of First Sale: 2025-11-14; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 120535618; Total Amount Sold: 48214232; Federal exemptions: 06b”
| Nov 14, 2025 | SEC Form D ↗ |
| Enrich Biosystems | SEC Form D Debt / note · Form D reports $1.45M sold of $1.5M offeredSource quote- Filed Nov 26, 2025 · SEC Form D ↗
“Name of Issuer: ENRICH BIOSYSTEMS INC.; CIK: 1931770; Address: Branford, CT; Submission type: D; Filing date: 2025-11-26; Industry Group: Biotechnology; Date of First Sale: 2025-11-13; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 1500000; Total Amount Sold: 1450000; Federal exemptions: 06b”
| Nov 13, 2025 | SEC Form D ↗ |
| Akura Medical | SEC Form D Equity · Form D reports $51.45M sold of $72M offeredSource quote- Filed Dec 3, 2025 · SEC Form D ↗
“Name of Issuer: Akura Medical, Inc.; CIK: 1902758; Address: Campbell, CA; Submission type: D; Filing date: 2025-12-03; Industry Group: Other Health Care; Date of First Sale: 2025-11-12; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 71999999; Total Amount Sold: 51449999; Federal exemptions: 06b”
| Nov 12, 2025 | SEC Form D ↗ |
| NanoViricides | SEC Form D Equity · Form D reports $6M soldSource quote- Filed Feb 25, 2026 · SEC Form D ↗
“Name of Issuer: NANOVIRICIDES, INC.; CIK: 1379006; Address: Shelton, CT; Submission type: D; Filing date: 2026-02-25; Industry Group: Pharmaceuticals; Date of First Sale: 2025-11-12; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 6000000; Total Amount Sold: 6000000; Federal exemptions: 06b”
| Nov 12, 2025 | SEC Form D ↗ |
| Ophthalmic Therapeutic Innovation | SEC Form D Equity · Form D reports $100K sold of $300K offeredSource quote- Filed Dec 2, 2025 · SEC Form D ↗
“Name of Issuer: Ophthalmic Therapeutic Innovation LLC; CIK: 2098204; Address: Watertown, MA; Submission type: D; Filing date: 2025-12-02; Industry Group: Biotechnology; Date of First Sale: 2025-11-08; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 300000; Total Amount Sold: 100000; Federal exemptions: 06b”
| Nov 8, 2025 | SEC Form D ↗ |
| VahatiCor | SEC Form D Equity · Form D reports $21.18M sold of $32.38M offeredSource quote- Filed Dec 4, 2025 · SEC Form D ↗
“Name of Issuer: VahatiCor, Inc.; CIK: 2042118; Address: Santa Clara, CA; Submission type: D; Filing date: 2025-12-04; Industry Group: Other Health Care; Date of First Sale: 2025-11-07; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 32383479; Total Amount Sold: 21183479; Federal exemptions: 06b”
| Nov 7, 2025 | SEC Form D ↗ |
| Spineology | SEC Form D Equity · Form D reports $12.64M sold of $14.08M offeredSource quote- Filed Nov 19, 2025 · amended Jun 17, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: SPINEOLOGY INC; CIK: 1165842; Address: St. Paul, MN; Submission type: D/A; Filing date: 2026-06-17; Industry Group: Biotechnology; Date of First Sale: 2025-11-07; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 14079337; Total Amount Sold: 12641849; Federal exemptions: 06b”
| Nov 7, 2025 | SEC Form D/A ↗ |
| Atrility Medical | SEC Form D Debt / note · Form D reports $1M sold of $2M offeredSource quote- Filed Feb 5, 2026 · SEC Form D ↗
“Name of Issuer: Atrility Medical, Inc.; CIK: 1734892; Address: Madison, WI; Submission type: D; Filing date: 2026-02-05; Industry Group: Other Health Care; Date of First Sale: 2025-11-07; Types of Securities Offered: Debt, Option/warrant; Business combination transaction: false; Total Offering Amount: 2000000; Total Amount Sold: 1000000; Federal exemptions: 06b”
| Nov 7, 2025 | SEC Form D ↗ |
| Pelthos Therapeutics | SEC Form D Debt / note · Form D reports $18M soldSource quote- Filed Nov 19, 2025 · SEC Form D ↗
“Name of Issuer: Pelthos Therapeutics Inc.; CIK: 1919246; Address: Durham, NC; Submission type: D; Filing date: 2025-11-19; Industry Group: Pharmaceuticals; Date of First Sale: 2025-11-06; Types of Securities Offered: Option/warrant, Security to be acquired, Other (Senior secured convertible notes, which are convertible into shares of the Company's common stock, par value $0.0001 per share.); Business combination transaction: false; Total Offering Amount: 18000000; Total Amount Sold: 18000000; Federal exemptions: 06b”
| Nov 6, 2025 | SEC Form D ↗ |
| Medicovestor | SEC Form D SAFE · Form D reports $3.16M sold of $4.06M offeredSource quote- Filed Dec 5, 2025 · SEC Form D ↗
“Name of Issuer: Medicovestor, Inc.; CIK: 2099357; Address: New York, NY; Submission type: D; Filing date: 2025-12-05; Industry Group: Biotechnology; Date of First Sale: 2025-11-05; Types of Securities Offered: Equity, Other (Simple Agreements for Future Equity); Business combination transaction: false; Total Offering Amount: 4064834; Total Amount Sold: 3164834; Federal exemptions: 06b”
| Nov 5, 2025 | SEC Form D ↗ |
| VST Bio | SEC Form D Equity · Form D reports $31.89M soldSource quote- Filed Nov 18, 2025 · amended Apr 24, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: VST BIO Corp; CIK: 2093250; Address: San Diego, CA; Submission type: D/A; Filing date: 2026-04-24; Industry Group: Pharmaceuticals; Date of First Sale: 2025-11-05; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 31888146; Total Amount Sold: 31888146; Federal exemptions: 06b”
| Nov 5, 2025 | SEC Form D/A ↗ |
| LifeLens Technologies | SEC Form D Equity · Form D reports $21.1M sold of $40M offeredSource quote- Filed Nov 17, 2025 · amended Sep 8, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: LifeLens Technologies, Inc.; CIK: 1782780; Address: Ivyland, PA; Submission type: D/A; Filing date: 2026-09-08; Industry Group: Other Technology; Date of First Sale: 2025-11-04; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 40000000; Total Amount Sold: 21104217; Federal exemptions: 06b”
| Nov 4, 2025 | SEC Form D/A ↗ |
| Invea Therapeutics | SEC Form D Equity · Form D reports $120K soldSource quote- Filed Dec 10, 2025 · SEC Form D ↗
“Name of Issuer: Invea Therapeutics, Inc; CIK: 1906425; Address: Guilford, CT; Submission type: D; Filing date: 2025-12-10; Industry Group: Biotechnology; Date of First Sale: 2025-10-31; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 120250; Total Amount Sold: 120250; Federal exemptions: 06b”
| Oct 31, 2025 | SEC Form D ↗ |
| Levee Medical | SEC Form D Debt / note · Form D reports $12.5M soldSource quote- Filed Nov 12, 2025 · amended May 5, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: Levee Medical, Inc.; CIK: 1877814; Address: Durham, NC; Submission type: D/A; Filing date: 2026-05-05; Industry Group: Other Health Care; Date of First Sale: 2025-10-31; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 12500000; Total Amount Sold: 12500000; Federal exemptions: 06b”
| Oct 31, 2025 | SEC Form D/A ↗ |
| Epalex | SEC Form D Equity · Form D reports $1.2M sold of $3.2M offeredSource quote- Filed Nov 10, 2025 · SEC Form D ↗
“Name of Issuer: EPALEX Corp; CIK: 1755010; Address: Mountain View, CA; Submission type: D; Filing date: 2025-11-10; Industry Group: Pharmaceuticals; Date of First Sale: 2025-10-31; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 3199991; Total Amount Sold: 1200000; Federal exemptions: 06b”
| Oct 31, 2025 | SEC Form D ↗ |
| Gut-Brain-Axis Therapeutics Inc. | SEC Form D Equity · Form D reports $1.97M sold of $20M offeredSource quote- Filed Nov 6, 2025 · SEC Form D ↗
“Name of Issuer: Gut-Brain-Axis Therapeutics Inc.; CIK: 1996678; Address: Tempe, AZ; Submission type: D; Filing date: 2025-11-06; Industry Group: Biotechnology; Date of First Sale: 2025-10-31; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 20000000; Total Amount Sold: 1965000; Federal exemptions: 06c”
| Oct 31, 2025 | SEC Form D ↗ |
| Elixirgen Therapeutics | SEC Form D Debt / note · Form D reports $4M soldSource quote- Filed Nov 13, 2025 · SEC Form D ↗
“Name of Issuer: ELIXIRGEN THERAPEUTICS, INC.; CIK: 1744333; Address: Baltimore, MD; Submission type: D; Filing date: 2025-11-13; Industry Group: Biotechnology; Date of First Sale: 2025-10-30; Types of Securities Offered: Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 4000000; Total Amount Sold: 4000000; Federal exemptions: 06b”
| Oct 30, 2025 | SEC Form D ↗ |
| Saluda Medical | SEC Form D Equity · Form D reports $30M soldSource quote- Filed Nov 12, 2025 · SEC Form D ↗
“Name of Issuer: Saluda Medical, Inc.; CIK: 1973574; Address: Bloomington, MN; Submission type: D; Filing date: 2025-11-12; Industry Group: Other Health Care; Date of First Sale: 2025-10-30; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 29999995; Total Amount Sold: 29999995; Federal exemptions: 06b”
| Oct 30, 2025 | SEC Form D ↗ |
| Model Medicines | SEC Form D Equity · Form D reports $3.26M sold of $5M offeredSource quote- Filed Nov 14, 2025 · SEC Form D ↗
“Name of Issuer: Model Medicines, Inc.; CIK: 1892786; Address: San Deigo, CA; Submission type: D; Filing date: 2025-11-14; Industry Group: Other; Date of First Sale: 2025-10-29; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 5000000; Total Amount Sold: 3260000; Federal exemptions: 06b”
| Oct 29, 2025 | SEC Form D ↗ |
| TearSolutions | SEC Form D Equity · Form D reports $517K soldSource quote- Filed Nov 10, 2025 · SEC Form D ↗
“Name of Issuer: TearSolutions, Inc.; CIK: 1611687; Address: Charlottesville, VA; Submission type: D; Filing date: 2025-11-10; Industry Group: Biotechnology; Date of First Sale: 2025-10-29; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 517000; Total Amount Sold: 517000; Federal exemptions: 06b”
| Oct 29, 2025 | SEC Form D ↗ |
| CoRegen | SEC Form D Equity · Form D reports $13.5M soldSource quote- Filed Feb 26, 2026 · SEC Form D ↗
“Name of Issuer: CoRegen, Inc.; CIK: 2012886; Address: Houston, TX; Submission type: D; Filing date: 2026-02-26; Industry Group: Biotechnology; Date of First Sale: 2025-10-28; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 13500000; Total Amount Sold: 13500000; Federal exemptions: 06b”
| Oct 28, 2025 | SEC Form D ↗ |
| TuHURA Biosciences Filed as TuHURA Biosciences, Inc./NV | SEC Form D Equity · Form D reports $1.5M sold of $3M offeredSource quote- Filed Nov 10, 2025 · SEC Form D ↗
“Name of Issuer: TuHURA Biosciences, Inc./NV; CIK: 1498382; Address: Tampa, FL; Submission type: D; Filing date: 2025-11-10; Industry Group: Biotechnology; Date of First Sale: 2025-10-27; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 1500000; Federal exemptions: 06b”
| Oct 27, 2025 | SEC Form D ↗ |
| Celularity | SEC Form D Equity · Form D reports $2M sold of $6.67M offeredSource quote- Filed Nov 3, 2025 · SEC Form D ↗
“Name of Issuer: Celularity Inc; CIK: 1752828; Address: Florham Park, NJ; Submission type: D; Filing date: 2025-11-03; Industry Group: Biotechnology; Date of First Sale: 2025-10-24; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 6666667; Total Amount Sold: 2000000; Federal exemptions: 06c”
| Oct 24, 2025 | SEC Form D ↗ |
| Rani Therapeutics Filed as Rani Therapeutics Holdings, Inc. | SEC Form D Equity · Form D reports $60.26M soldSource quote- Filed Nov 10, 2025 · SEC Form D ↗
“Name of Issuer: Rani Therapeutics Holdings, Inc.; CIK: 1856725; Address: San Jose, CA; Submission type: D; Filing date: 2025-11-10; Industry Group: Biotechnology; Date of First Sale: 2025-10-23; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 60255052; Total Amount Sold: 60255052; Federal exemptions: 06b”
| Oct 23, 2025 | SEC Form D ↗ |
| Antigenix Therapeutics | SEC Form D Equity · Form D reports $3.36M sold of $8.36M offeredSource quote- Filed Oct 24, 2025 · SEC Form D ↗
“Name of Issuer: Antigenix Therapeutics, Inc.; CIK: 2073993; Address: Princeton, NJ; Submission type: D; Filing date: 2025-10-24; Industry Group: Other Health Care; Date of First Sale: 2025-10-22; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 8363695; Total Amount Sold: 3363695; Federal exemptions: 06b”
| Oct 22, 2025 | SEC Form D ↗ |
| GEn1E Lifesciences | SEC Form D Equity · Form D reports $5.52M sold of $11.89M offeredSource quote- Filed Dec 29, 2025 · SEC Form D ↗
“Name of Issuer: GEN1E LIFESCIENCES INC.; CIK: 1752886; Address: Palo Alto, CA; Submission type: D; Filing date: 2025-12-29; Industry Group: Biotechnology; Date of First Sale: 2025-10-21; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 11887377; Total Amount Sold: 5520803; Federal exemptions: 06b”
| Oct 21, 2025 | SEC Form D ↗ |
| Alto Neuroscience, Inc. | SEC Form D Equity · Form D reports $50M soldSource quote- Filed Oct 27, 2025 · SEC Form D ↗
“Name of Issuer: Alto Neuroscience, Inc.; CIK: 1999480; Address: Mountain View, CA; Submission type: D; Filing date: 2025-10-27; Industry Group: Pharmaceuticals; Date of First Sale: 2025-10-21; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 49999533; Total Amount Sold: 49999533; Federal exemptions: 06b”
| Oct 21, 2025 | SEC Form D ↗ |
| XDemics | SEC Form D Equity · Form D reports $7.4M soldSource quote- Filed Feb 6, 2026 · SEC Form D ↗
“Name of Issuer: XDemics Corp; CIK: 2026725; Address: San Rafael, CA; Submission type: D; Filing date: 2026-02-06; Industry Group: Biotechnology; Date of First Sale: 2025-10-21; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 7399999; Total Amount Sold: 7399999; Federal exemptions: 06b”
| Oct 21, 2025 | SEC Form D ↗ |
| Osteal Therapeutics | SEC Form D Equity · Form D reports $15.6M sold of $26.7M offered · filed Nov 5, 2025Source quote- Filed Nov 5, 2025 · SEC Form D ↗
“Name of Issuer: Osteal Therapeutics, Inc.; CIK: 1735936; Address: Dallas, TX; Submission type: D; Filing date: 2025-11-05; Industry Group: Pharmaceuticals; Date of First Sale: 2025-10-17; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 26702156; Total Amount Sold: 15602151; Federal exemptions: 06b”
| Oct 17, 2025 | SEC Form D ↗ |
| Andson Biotech | SEC Form D Equity · Form D reports $4.74M sold of $5M offered · filed Oct 22, 2025Source quote- Filed Oct 22, 2025 · SEC Form D ↗
“Name of Issuer: Andson Biotech Inc.; CIK: 2017131; Address: Atlanta, GA; Submission type: D; Filing date: 2025-10-22; Industry Group: Biotechnology; Date of First Sale: 2025-10-17; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 5000000; Total Amount Sold: 4735000; Federal exemptions: 06b”
| Oct 17, 2025 | SEC Form D ↗ |
| Vesteck, Inc. | SEC Form D Equity · Form D reports $354K sold of $500K offered · filed Oct 30, 2025Source quote- Filed Oct 30, 2025 · SEC Form D ↗
“Name of Issuer: VESTECK, INC.; CIK: 1882165; Address: Carlsbad, CA; Submission type: D; Filing date: 2025-10-30; Industry Group: Other Technology; Date of First Sale: 2025-10-16; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 500000; Total Amount Sold: 353578; Federal exemptions: 06b”
| Oct 16, 2025 | SEC Form D ↗ |
| Luminary Therapeutics | SEC Form D Equity · Form D reports $1.41M sold of $12.39M offered · filed Nov 5, 2025Source quote- Filed Nov 5, 2025 · SEC Form D ↗
“Name of Issuer: Luminary Therapeutics, Inc.; CIK: 1793860; Address: Minneapolis, MN; Submission type: D; Filing date: 2025-11-05; Industry Group: Biotechnology; Date of First Sale: 2025-10-14; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 12388157; Total Amount Sold: 1406112; Federal exemptions: 06b”
| Oct 14, 2025 | SEC Form D ↗ |
| SFC Fluidics | SEC Form D Equity · Form D reports $250K sold of $650K offered · filed Oct 24, 2025Source quote- Filed Oct 24, 2025 · SEC Form D ↗
“Name of Issuer: SFC FLUIDICS INC.; CIK: 1352226; Address: Fayetteville, AR; Submission type: D; Filing date: 2025-10-24; Industry Group: Other; Date of First Sale: 2025-10-13; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 650000; Total Amount Sold: 250000; Federal exemptions: 06b”
| Oct 13, 2025 | SEC Form D ↗ |
| ENDRA Life Sciences | SEC Form D Equity · Form D reports $14.4M sold · filed Oct 24, 2025Source quote- Filed Oct 24, 2025 · SEC Form D ↗
“Name of Issuer: ENDRA Life Sciences Inc.; CIK: 1681682; Address: Ann Arbor, MI; Submission type: D; Filing date: 2025-10-24; Industry Group: Biotechnology; Date of First Sale: 2025-10-10; Types of Securities Offered: Equity, Other (Prefunded and Common Warrants to purchase shares of Common Stock); Business combination transaction: false; Total Offering Amount: 14402880; Total Amount Sold: 14402880; Federal exemptions: 06c”
| Oct 10, 2025 | SEC Form D ↗ |
| MarvelBiome | SEC Form D Equity · Form D reports $39.56M sold of $52.5M offered · filed Oct 22, 2025Source quote- Filed Oct 22, 2025 · SEC Form D ↗
“Name of Issuer: MarvelBiome, Inc.; CIK: 1815665; Address: Woburn, MA; Submission type: D; Filing date: 2025-10-22; Industry Group: Biotechnology; Date of First Sale: 2025-10-10; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 52503006; Total Amount Sold: 39561794; Federal exemptions: 06b”
| Oct 10, 2025 | SEC Form D ↗ |
| Eyconis | SEC Form D Equity · Form D reports $25M sold of $89.75M offered · filed Oct 22, 2025Source quote- Filed Oct 22, 2025 · SEC Form D ↗
“Name of Issuer: Eyconis, Inc.; CIK: 2010730; Address: Redwood City, CA; Submission type: D; Filing date: 2025-10-22; Industry Group: Other; Date of First Sale: 2025-10-08; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 89750003; Total Amount Sold: 24999996; Federal exemptions: 06b”
| Oct 8, 2025 | SEC Form D ↗ |
| Cleveland Diagnostics | SEC Form D Equity · Form D reports $14.42M sold · filed Oct 20, 2025Source quote- Filed Oct 20, 2025 · SEC Form D ↗
“Name of Issuer: Cleveland Diagnostics, Inc.; CIK: 1637038; Address: Cleveland, OH; Submission type: D; Filing date: 2025-10-20; Industry Group: Biotechnology; Date of First Sale: 2025-10-07; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 14421653; Total Amount Sold: 14421653; Federal exemptions: 06b”
| Oct 7, 2025 | SEC Form D ↗ |
| Blue Marlin Therapeutics | SEC Form D Equity · Form D reports $100K sold (offering size open-ended) · filed Oct 21, 2025Source quote- Filed Oct 21, 2025 · SEC Form D ↗
“Name of Issuer: Blue Marlin Therapeutics, Inc.; CIK: 2092364; Address: Charlottesville, VA; Submission type: D; Filing date: 2025-10-21; Industry Group: Biotechnology; Date of First Sale: 2025-10-06; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 100000; Federal exemptions: 06b”
| Oct 6, 2025 | SEC Form D ↗ |
| Ironfist Therapeutics | SEC Form D Equity · Form D reports $2K sold of $2K offered · filed Oct 20, 2025Source quote- Filed Oct 20, 2025 · SEC Form D ↗
“Name of Issuer: Ironfist Therapeutics, Inc.; CIK: 2091572; Address: Campbell, CA; Submission type: D; Filing date: 2025-10-20; Industry Group: Other Technology; Date of First Sale: 2025-10-04; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 1800; Total Amount Sold: 1750; Federal exemptions: 06b”
| Oct 4, 2025 | SEC Form D ↗ |
| Moat Biotechnology Corporation | SEC Form D Equity · Form D reports $26K sold of $15.59M offered · filed Oct 20, 2025Source quote- Filed Oct 20, 2025 · SEC Form D ↗
“Name of Issuer: MOAT BIOTECHNOLOGY Corp; CIK: 1944095; Address: Oklahoma City, OK; Submission type: D; Filing date: 2025-10-20; Industry Group: Biotechnology; Date of First Sale: 2025-10-03; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 15593738; Total Amount Sold: 26400; Federal exemptions: 06b”
| Oct 3, 2025 | SEC Form D ↗ |
| Mercury Bio | SEC Form D Equity · Form D reports $2.38M sold of $7.95M offered · filed Oct 24, 2025Source quote- Filed Oct 24, 2025 · SEC Form D ↗
“Name of Issuer: Mercury Bio, Inc.; CIK: 1952927; Address: Santa FE, NM; Submission type: D; Filing date: 2025-10-24; Industry Group: Biotechnology; Date of First Sale: 2025-09-30; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 7954094; Total Amount Sold: 2376107; Federal exemptions: 06b”
| Sep 30, 2025 | SEC Form D ↗ |
| Spiral Therapeutics | SEC Form D Equity · Form D reports $27.09M sold · filed Apr 16, 2026Source quote- Filed Apr 16, 2026 · SEC Form D ↗
“Name of Issuer: Spiral Therapeutics Inc; CIK: 1761906; Address: South San Francisco, CA; Submission type: D; Filing date: 2026-04-16; Industry Group: Pharmaceuticals; Date of First Sale: 2025-09-30; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 27089842; Total Amount Sold: 27089839; Federal exemptions: 06b”
| Sep 30, 2025 | SEC Form D ↗ |
| Corner Therapeutics | SEC Form D Debt / note · Form D reports $16.75M sold · filed Oct 20, 2025Source quote- Filed Oct 20, 2025 · SEC Form D ↗
“Name of Issuer: Corner Therapeutics, Inc.; CIK: 2019875; Address: Watertown, MA; Submission type: D; Filing date: 2025-10-20; Industry Group: Pharmaceuticals; Date of First Sale: 2025-09-26; Types of Securities Offered: Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 16754446; Total Amount Sold: 16754446; Federal exemptions: 06b”
| Sep 26, 2025 | SEC Form D ↗ |
| inSoma Bio, Inc. | SEC Form D SAFE · Form D reports $2.69M sold of $4M offered · filed Oct 20, 2025Source quote- Filed Oct 20, 2025 · amended Jan 22, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: inSoma Bio, Inc.; CIK: 1814250; Address: Durham, NC; Submission type: D/A; Filing date: 2026-01-22; Industry Group: Biotechnology; Date of First Sale: 2025-09-24; Types of Securities Offered: Other (Simple Agreement for Future Equity); Business combination transaction: false; Total Offering Amount: 4000000; Total Amount Sold: 2689372; Federal exemptions: 06b”
| Sep 24, 2025 | SEC Form D/A ↗ |
| Nirrin Technologies Inc. | SEC Form D Equity · Form D reports $6.7M sold of $9.71M offered · filed Jun 15, 2026Source quote- Filed Jun 15, 2026 · SEC Form D ↗
“Name of Issuer: Nirrin Technologies, Inc.; CIK: 1889145; Address: Billerica, MA; Submission type: D; Filing date: 2026-06-15; Industry Group: Biotechnology; Date of First Sale: 2025-09-23; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 9711196; Total Amount Sold: 6699781; Federal exemptions: 06b”
| Sep 23, 2025 | SEC Form D ↗ |
| Carolina Molecular | SEC Form D Equity · Form D reports $1.12M sold of $1.7M offered · filed Nov 13, 2025Source quote- Filed Nov 13, 2025 · SEC Form D ↗
“Name of Issuer: Carolina Molecular Inc.; CIK: 2096691; Address: Morrisville, NC; Submission type: D; Filing date: 2025-11-13; Industry Group: Biotechnology; Date of First Sale: 2025-09-17; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 1700000; Total Amount Sold: 1125000; Federal exemptions: 06b”
| Sep 17, 2025 | SEC Form D ↗ |
| ABLi Therapeutics, Inc. | SEC Form D Equity · Form D reports $1M sold · filed Jan 13, 2026Source quote- Filed Jan 13, 2026 · SEC Form D ↗
“Name of Issuer: ABLi Therapeutics, Inc.; CIK: 2104142; Address: Atlanta, GA; Submission type: D; Filing date: 2026-01-13; Industry Group: Pharmaceuticals; Date of First Sale: 2025-09-15; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 1000000; Total Amount Sold: 1000000; Federal exemptions: 06b”
| Sep 15, 2025 | SEC Form D ↗ |
| Epibone, Inc. | SEC Form D Equity · Form D reports $4.29M sold of $4.3M offered · filed Oct 24, 2025Source quote- Filed Oct 24, 2025 · SEC Form D ↗
“Name of Issuer: EpiBone, Inc.; CIK: 1798436; Address: New York, NY; Submission type: D; Filing date: 2025-10-24; Industry Group: Other; Date of First Sale: 2025-09-02; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 4300506; Total Amount Sold: 4287429; Federal exemptions: 06b”
| Sep 2, 2025 | SEC Form D ↗ |
| Protein Dynamic Solutions | SEC Form D Equity · Form D reports $1.77M sold (offering size open-ended) · filed Nov 7, 2025Source quote- Filed Nov 7, 2025 · SEC Form D ↗
“Name of Issuer: Protein Dynamic Solutions, Inc.; CIK: 1780775; Address: Wilmington, DE; Submission type: D; Filing date: 2025-11-07; Industry Group: Biotechnology; Date of First Sale: 2025-08-13; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 1772369; Federal exemptions: 06b”
| Aug 13, 2025 | SEC Form D ↗ |
| Aethl Bio | SEC Form D SAFE · Form D reports $1.64M sold of $5M offered · filed Apr 17, 2026Source quote- Filed Apr 17, 2026 · SEC Form D ↗
“Name of Issuer: Aethl Bio, Inc.; CIK: 2116929; Address: Pittsburgh, PA; Submission type: D; Filing date: 2026-04-17; Industry Group: Biotechnology; Date of First Sale: 2025-07-14; Types of Securities Offered: Security to be acquired, Other (Simple Agreement for Future Equity (SAFE)); Business combination transaction: false; Total Offering Amount: 5000000; Total Amount Sold: 1635000; Federal exemptions: 06b”
| Jul 14, 2025 | SEC Form D ↗ |
| Dualitas Therapeutics | SEC Form D Equity · Form D reports $32.6M sold of $66.6M offered · filed Nov 18, 2025Source quote- Filed Nov 18, 2025 · SEC Form D ↗
“Name of Issuer: Dualitas Therapeutics, Inc.; CIK: 2091994; Address: South San Francisco, CA; Submission type: D; Filing date: 2025-11-18; Industry Group: Biotechnology; Date of First Sale: 2025-07-07; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 66599990; Total Amount Sold: 32599997; Federal exemptions: 06b”
| Jul 7, 2025 | SEC Form D ↗ |
| Instylla | SEC Form D Equity · Form D reports $34.78M sold of $35.03M offered · filed Oct 23, 2025Source quote- Filed Oct 23, 2025 · amended Jul 28, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: Instylla, Inc.; CIK: 1708696; Address: Bedford, MA; Submission type: D/A; Filing date: 2026-07-28; Industry Group: Biotechnology; Date of First Sale: 2025-07-07; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 35034025; Total Amount Sold: 34783984; Federal exemptions: 06b”
| Jul 7, 2025 | SEC Form D/A ↗ |
| Odyssey Therapeutics (2) Filed as Odyssey Therapeutics, Inc. | SEC Form D Equity · Form D reports $214.03M sold · filed Dec 4, 2025Source quote- Filed Dec 4, 2025 · SEC Form D ↗
“Name of Issuer: Odyssey Therapeutics, Inc.; CIK: 1882782; Address: Boston, MA; Submission type: D; Filing date: 2025-12-04; Industry Group: Biotechnology; Date of First Sale: 2025-06-16; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 214025200; Total Amount Sold: 214025200; Federal exemptions: 06b”
| Jun 16, 2025 | SEC Form D ↗ |
| Strand Therapeutics | SEC Form D Equity · Form D reports $108.1M sold of $120.1M offered · filed Mar 17, 2026Source quote- Filed Mar 17, 2026 · SEC Form D ↗
“Name of Issuer: Strand Therapeutics Inc.; CIK: 1778475; Address: Boston, MA; Submission type: D; Filing date: 2026-03-17; Industry Group: Biotechnology; Date of First Sale: 2025-05-23; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 120099940; Total Amount Sold: 108099927; Federal exemptions: 06b”
| May 23, 2025 | SEC Form D ↗ |
| Strategikon Pharma | SEC Form D Debt / note · Form D reports $2.29M sold of $3M offered · filed Nov 21, 2025Source quote- Filed Nov 21, 2025 · SEC Form D ↗
“Name of Issuer: Strategikon Pharma, Inc.; CIK: 1722200; Address: San Francisco, CA; Submission type: D; Filing date: 2025-11-21; Industry Group: Other Technology; Date of First Sale: 2025-05-08; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 2291885; Federal exemptions: 06b”
| May 8, 2025 | SEC Form D ↗ |
| Eliaz Therapeutics | SEC Form D SAFE · Form D reports $850K sold · filed Oct 24, 2025Source quote- Filed Oct 24, 2025 · SEC Form D ↗
“Name of Issuer: Eliaz Therapeutics Inc.; CIK: 2042609; Address: Santa Rosa, CA; Submission type: D; Filing date: 2025-10-24; Industry Group: Biotechnology; Date of First Sale: 2025-03-28; Types of Securities Offered: Other (SAFEs); Business combination transaction: false; Total Offering Amount: 850000; Total Amount Sold: 850000; Federal exemptions: 06b”
| Mar 28, 2025 | SEC Form D ↗ |
| Bot Image | SEC Form D Equity + debt/notes · Form D reports $280K sold of $1M offered · filed Oct 20, 2025Source quote- Filed Oct 20, 2025 · SEC Form D ↗
“Name of Issuer: Bot Image, Inc.; CIK: 1778258; Address: Omaha, NE; Submission type: D; Filing date: 2025-10-20; Industry Group: Other; Date of First Sale: 2025-01-08; Types of Securities Offered: Equity, Debt; Business combination transaction: false; Total Offering Amount: 1000000; Total Amount Sold: 280000; Federal exemptions: 06b”
| Jan 8, 2025 | SEC Form D ↗ |
| Immorta Bio | SEC Form D Equity · Form D reports $613K sold of $5M offered · filed Oct 16, 2026Source quote- Filed Oct 16, 2026 · SEC Form D ↗
“Name of Issuer: Immorta Bio, Inc.; CIK: 2102665; Address: Miami Beach, FL; Submission type: D; Filing date: 2026-10-16; Industry Group: Biotechnology; Date of First Sale: 2024-11-05; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 5000000; Total Amount Sold: 612503; Federal exemptions: 06c”
| Nov 5, 2024 | SEC Form D ↗ |
| ProEncia Biotechnology | SEC Form D Equity + debt/notes · Form D reports $1.51M sold of $2M offered · filed Aug 26, 2026Source quote- Filed Aug 26, 2026 · SEC Form D ↗
“Name of Issuer: ProEncia Biotechnology Inc.; CIK: 2103044; Address: Woodbury, MN; Submission type: D; Filing date: 2026-08-26; Industry Group: Biotechnology; Date of First Sale: 2024-10-04; Types of Securities Offered: Equity, Debt; Business combination transaction: false; Total Offering Amount: 2000000; Total Amount Sold: 1510000; Federal exemptions: 06b”
| Oct 4, 2024 | SEC Form D ↗ |
| Jabez Biosciences | SEC Form D Equity · Form D reports $31K sold (offering size open-ended) · filed Mar 26, 2026Source quote- Filed Mar 26, 2026 · SEC Form D ↗
“Name of Issuer: Jabez Biosciences, Inc.; CIK: 2038185; Address: Cranberry Twp., PA; Submission type: D; Filing date: 2026-03-26; Industry Group: Biotechnology; Date of First Sale: 2024-06-11; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 31200; Federal exemptions: 06b”
| Jun 11, 2024 | SEC Form D ↗ |
| NOK Therapeutics | SEC Form D Equity · Form D reports $3K sold · filed Mar 26, 2026Source quote- Filed Mar 26, 2026 · amended May 1, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: Nok Therapeutics, Inc.; CIK: 2038166; Address: Cranberry Twp., PA; Submission type: D/A; Filing date: 2026-05-01; Industry Group: Biotechnology; Date of First Sale: 2024-06-11; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 3200; Total Amount Sold: 3200; Federal exemptions: 06b”
| Jun 11, 2024 | SEC Form D/A ↗ |
| Kaida BioPharma | SEC Form D Equity · Form D reports $1.6M sold of $4.1M offered · filed Jan 21, 2026Source quote- Filed Jan 21, 2026 · amended Sep 1, 2026 · SEC Form D/A ↗ · original Form D ↗
“Name of Issuer: Kaida BioPharma Inc.; CIK: 1973954; Address: Fort Lauderdale, FL; Submission type: D/A; Filing date: 2026-09-01; Industry Group: Biotechnology; Date of First Sale: 2023-10-24; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 4100507; Total Amount Sold: 1600507; Federal exemptions: 06b”
| Oct 24, 2023 | SEC Form D/A ↗ |
| Elidah | SEC Form D Equity · Form D reports $2.02M sold of $2.5M offered · filed Apr 6, 2026Source quote- Filed Apr 6, 2026 · SEC Form D ↗
“Name of Issuer: Elidah, Inc.; CIK: 2113916; Address: Newtown, CT; Submission type: D; Filing date: 2026-04-06; Industry Group: Manufacturing; Date of First Sale: 2023-06-02; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 2500000; Total Amount Sold: 2018000; Federal exemptions: 06b”
| Jun 2, 2023 | SEC Form D ↗ |